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The human lung is exposed daily to over 10,000 liters of inspired, 
ambient air and the continuous aspiration of small amounts of nasopha- 
ryngeal secretions during sleep (Kikuchi et al., 1994). Depending on 
the quality of air in the environment or the resident flora in the naso- 
pharynx, the respiratory tree faces the enormous task of oxygenat- 
ing blood across a moist, thin alveolar-capillary wall (approximately 
1 pm) and yet resisting infection. Mechanical mechanisms and other 
innate host defenses are important in preventing infection, but ac- 
quired immunity is essential to prevent recurrent and chronic infection 
as made strikingly evident by the increased numbers and severity of 
pulmonary infections in immunocompromised hosts (Newhouse et al., 
1976; Mason and Nelson, 1992). 
The lung, as is true of other epithelial surfaces that interface with 
the environment, has developed several strategies to avoid infection. 
As an important component ofthese strategies, the host must be able to 
downregulate both nonspecific and immune-mediated inflammation. 
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Failure to regulate local immunity results in diseases such as asthma, 
hypersensitivity pneumonitis, and perhaps sarcoidosis and idiopathic 
interstitial pneumonitis (Holt, 1993; Djukanovic et al., 1990; O’Connor 
and FitzGerald, 1992). Thus, the desire to enhance protective pul- 
monary immune responses by vaccination and to prevent or control 
unwanted responses underlie the need to study basic immune 
mechanisms in the lung. Furthermore, understanding critical 
immunoregulatory mechanisms may lead to strategies for preventing 
and controlling lung transplant rejection and immune-mediated lung 
damage in bone marrow transplant patients. 
A number of recent reviews have discussed important issues in the 
development of pulmonary immune responses (Agostini et al., 1993; 
Hance, 1993; Lipscomb et al., 1993a; Gyetko and Toews, 1993; Holt, 
1993; Bice, 1993). The goal of this chapter is to describe the cells and 
structures of the lung that participate in pulmonary immunity and to 
summarize studies that help explain how the lung responds to chal- 
lenges with foreign antigens, with particular emphasis on animal mod- 
els that have been developed to explore these issues. Features of the 
immune apparatus that are unique to the lung will be highlighted, and 
important questions currently under investigation will be indicated. 
II. Immune Cells and Structures of the lung 
An important challenge is to understand how the host protects itself 
from infection yet regulates immunity to prevent tissue damage. Tissue 
culture has been a powerful tool for understanding how immunologi- 
cally relevant cells interact. The study of how various extracellular 
signals influence gene expression in cultured cells has given important 
insight into how the milieu could influence cell behavior at various 
anatomic sites. However, because it is not yet possible to know what 
all of the influences within a tissue are, hypotheses generated from 
cells in culture must be tested in uiuo. For example, alveolar macro- 
phages (AM) exist attached to epithelial cells and migrate within a 
layer of surfactant rather than attached to plastic in a layer of medium. 
A recent review in this series discussed the importance of placing 
lymphocytes in their spatial context within the host to properly under- 
stand their function (Kroemer et al., 1993). This consideration is espe- 
cially important in the lung. 
In considering the development of pulmonary immunity in a spatial 
context, it is useful to divide the evolution of an immune response in 
the lung into three distinct but overlapping phases (see Fig. 1; Lips- 
comb, 1993a): (1) in the afferent phase, antigen reaches the lung, is 
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FIG. 1. A model for afferent, central processing, and efferent phases of a pulmonary 
immune response. In the afferent phase (Aff), antigen that reaches bronchoalveolar 
spaces can directly enter lymphatics (L) or be processed by intraepithelial or interstitial 
dendritic cells (DC) that enter lymphatics and migrate to lung-associated lymph nodes 
(LALN). In the central processing phase (CP) antigen on lung DCs (or, perhaps, antigen 
processed by resident lymph node DCs) present antigen to T lymphocytes (T) to initiate 
the expansion of T cell clones that, in turn, may help B cells expand when B cell 
immunoglobulin receptors recognize “native” antigenic determinants. In the efferent 
phase (Eff), recently activated T cells and B cells (not shown) leave LALNs and circulate; 
they are subsequently recruited to the lung at sites of inflammation. Exposure of T cells 
to relevant antigen results in the release of cytokines that amplify an inflammatory 
response by recruiting nonspecific effector cells, such as monocytes (M), to the site and 
activating them to kill and/or growth-inhibit microorganisms. 
take up by antigen-presenting cells (APCs), and presented to naive 
T cells expressing the relevant T cell receptors (TCRs); (2) in the cen- 
tral processing phase, specific lymphocyte clones are expanded and 
differentiate; and (3) in the effector phase, effector T cells and B 
lymphoblasts find their way to pulmonary sites requiring expression 
of a specific immune response. At each phase, events must be tightly 
regulated to allow an effective immune response yet avoid excess, 
potentially destructive inflammation. The location in the respiratory 
tract where each of these phases occurs is somewhat controversial, 
but the bulk of evidence indicates that in the normal host after reaching 
the lungs, antigen is carried on APCs, in phagocytes, or free in lym- 
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phatic fluid to draining lung-associated lymph nodes (LALNs) (Lauwer- 
yns and Baert, 1976-1977; Lehnert, 1992) where central processing 
occurs. Effector cells are released into the efferent lymph and reach 
the blood stream where they are recruited from the vasculature into 
the lung (Berman et al., 1990). 
Many investigations have considered the lung in the broader context 
of mucosal immunity. This conceptual framework is useful, but the 
respiratory tract has several distinctive features that require that initia- 
tion and expression of lung immunity be considered separately from 
immune responses at other mucosal sites. 
A. CONCEPT OF AN UPPER AND LOWER RESPIRATORY TRACT 
The respiratory tract shares features of other organs, i.e., skin, gut, 
and urogenital tract in which an epithelial layer interacts with the 
environment. For internal organs, the concept of a common mucosal 
system was developed based on evidence that immune lymphocytes 
generated at one surface migrated to both homologous and distant 
mucosal sites (McDermott and Bienenstock, 1979; McGhee et al., 
1992). We will return to this concept shortly, but in addition to this 
concept, the lung must be understood immunologically from the point 
of view that both an upper and lower respiratory tract system exist 
(Kaltreider, 1976; Kazmierowski et al., 1977), and each system exhibits 
distinctive as well as common immune mechanisms. 
The upper respiratory tract starts at the nares and extends to the 
level of the terminal bronchioles. A pseudo stratified to single layered 
columnar epithelium covers vascularized connective tissue, the lamina 
propria, which, depending on the level of the airway, also contains 
variable numbers of mucous glands, smooth muscle, and, in the larger 
airways, is bounded by cartilage. By contrast, in the lower respiratory 
tract (which by definition includes the alveolar ducts and alveoli), the 
epithelium is markedly attenuated and frequently separated from the 
pulmonary capillary endothelium by only a fused basement mem- 
brane. The mechanisms of antigen handling and the types, location, 
and numbers of immunologically relevant cells differ even within 
areas of the upper respiratory tract, but are most strikingly different 
between the upper versus lower respiratory tracts. For example, muco- 
ciliary clearance is the major mechanism for clearance of particulates 
in the upper tract. In contrast, phagocytosis by resident AM which 
subsequently attain the level of the upper tract to be removed by the 
mucociliary elevator characterizes particulate clearance in the lower 
tract (Lauweryns and Baert, 1976-1977; Lehnert, 1992). 
Another distinctive feature of the upper versus lower tracts relates 
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to the organization of lymphoid tissue. In the upper tract, lymphocytes 
reside in both aggregates and diffusely distributed along the mucosa 
of the upper tract, and in some animal species may infiltrate the epithe- 
lium (Bienenstock et al., 1973a,b; Sminia et al., 1989). In the lower 
tract, lymphocytes are present in variable numbers both within alveoli 
and in the interstitium, but, in the normal host, organized aggregates 
do not occur (Sminia et al., 1989; Pabst, 1992). 
Other important features of the upper versus lower tract involve 
the relative importance of IgA as the protective antibody. Thus, IgA- 
secreting B cells occur in the mucosa of the upper tract, and IgA is 
the major immunoglobulin in secretions of the upper respiratory tract; 
although IgA is present in the lower tract, IgG and IgM predominate 
in bronchoalveolar lavage (BAL) fluids (Kaltreider, 1976). 
The development of immunity in the lung, as elsewhere, requires 
that relevant cells display appropriate surface molecules for contact 
and secrete appropriate factors. Some ligand-receptor interactions are 
specific while others are not, and it is the particular pattern of surface 
molecules and secreted factors expressed by interacting immune cells 
that determines the type of immune response that develops during 
central processing. Furthermore, at sites of pulmonary inflammation, 
other patterns of adhesion molecules and cytokine/chemokine expres- 
sion by immune and parenchymal cells direct the tempo and magni- 
tude of accumulation of recruited cells. Many recent studies emphasize 
the critical importance of cytokines and chemokines and the expression 
of adhesion molecules in regulating pulmonary inflammation and im- 
munity (Kunkel et al., 1989; Stein-Streilein and Phipps, 1993; Reding- 
ton et al., 1993; Standiford et al., 1993; Jordana et al., 1993; Lukacs 
et al., 1994a). 
The cells that are the major initiators and regulators of immunity in 
the lung include macrophages, dendritic cells (DCs), and lymphocytes, 
each expressing surface molecules and secretory products that depend 
on perturbations in the environments. However, other cells in the 
milieu, e.g., epithelial cells, fibroblasts, mast cells, and various re- 
cruited blood leukocytes, also play important regulatory roles which 
will only be briefly examined in subsequent sections. First, however, 
the special feature of lung macrophages, DCs, and lymphocytes are 
discussed. 
B. LUNG MACROPHAGES 
Originally proposed as important APCs in the lung (Lipscomb, 
1988), this diverse group of cells is now best understood in the context 
of lung immunity as phagocytes and as regulators of both immunity 
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and nonspecific inflammation (Holt, 1986; Lipscomb et al., 1993a). 
Indeed, the bulk of evidence indicates lung macrophages are unlikely 
APCs in the initiation ofprimary immune responses. These cells reside 
within the airways at all levels of the respiratory tract, in the lamina 
propria, the interstitium, the alveolar regions and pleura, and within 
pleural spaces; in ruminant species, lung macrophages are found 
within the pulmonary capillaries (Lehnert, 1992; Brain, 1992). All lung 
macrophages originate from the bone marrow (van Oud Alblas et al., 
1983; Springmeyer et al., 1982; Godleski and Brain, 1972), but mainte- 
nance of at least some of these resident populations partly derives 
from self-replicating pools (Pinkett et al., 1966; Bowden and Adamson, 
1980; Sorokin et al., 1984; Tarling et al., 1987; Shellito et al., 1987). 
Pulmonary macrophages are both phenotypically and functionally 
diverse, even within a single compartment. Because of ready access 
to bronchoalveolar macrophages using BAL, the diversity of these cells 
has been most frequently studied. Macrophages obtained by lavage 
include resident AM as well as macrophages that reside within the 
lumen of the bronchi and bronchioles (intraluminal macrophages); a 
distinction between these two cell populations cannot be readily made. 
However, the vast majority of cells obtained during a human lavage 
are from the alveoli, since the technique is performed with a wedged 
flexible fiberoptic bronchoscope and the large alveolar surface area 
relative to the bronchial surface area is sampled (Reynolds, 1987; 
American Thoracic Society, 1990). In small rodents, e.g., mice and 
rats, a catheter is typically placed in the trachea and a larger proportion 
of the recovered cells are from the bronchi and bronchioles, but the 
majority of cells are still from alveoli if the procedure is performed 
correctly. 
Functional attributes of subpopulations of resident AM have been 
studied. Most studies exploit the differences in density (Murphy and 
Herscowitz, 1984; Shellito and Kaltreider, 1985; Oghiso, 1987), pre- 
dominantly a function of cell size. Another fractionation technique 
depends on differences in the cells’ capacity to be readily lavaged, a 
function of their adherence to epithelium and/or their residence in 
the bronchial lumen versus in alveoli (Holt et al., 1982). Within subpop- 
ulations, AM differ in expression of class I1 major histocompatibility 
antigens (MHC), Fc and complement receptors, phagocytic capacity, 
responses to chemotactic stimuli, cytotoxicity, cytokine production, 
and capacity to suppress in vitro immune responses (Holt et al., 1982; 
Murphy and Herscowitz, 1984; Shellito et al., 1983; Shellito and Kal- 
treider, 1985; Oghiso, 1987). Furthermore, the size, function, and phe- 
notype of AM shifts during an inflammatory response (van Oud Alblas 
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et al., 1983). Although alternate explanations for these changes have 
been offered, the most likely one is that AM recently arrived from the 
peripheral blood are similar in the size and phenotype to circulating 
monocytes, the precursors of AM. Thus, in the study of AM and their 
subpopulations and, indeed, in any study of lung immunity, it has 
become a dictum that investigators must be careful to avoid low levels 
of chronic inflammation by housing experimental animals in specific 
pathogen-free environments. Because respiratory infections are so com- 
mon in nearly all animal species and can markedly affect experimental 
results, this consideration cannot be overstated. 
Interstitial macrophages (IM) when compared with AM also exhibit 
size, functional, and phenotypic differences. These differences may 
reflect the stage of differentiation from blood precursors, but more 
likely reflect the environment and physiological roles of phagocytes 
in these two distinct locations. Important membrane molecules that 
determine the function of macrophages include complement, Fc, man- 
nose, and scavenger receptors, as well as class I and I1 MHC, adhesion, 
and other signaling molecules. Important differences in many of these 
exist depending on the location of lung macrophages. For example, 
in mice, IM express C3 receptors, whereas most resident AM do not 
(van Oud Alblas and Van Furth, 1979). 
Few studies exist on the role of interstitial, pleural, or intravascular 
lung macrophages in immune responses. However, numerous studies 
have examined the role of AM in stimulating mitogen, alloantigen, 
and antigen stimulated responses in vitro. Not surprisingly, these stud- 
ies have often reached conflicting conclusions, a result of the differing 
animal species used, the level of superimposed AM suppressive activ- 
ity, and the assay procedure that was used (Holt, 1986; Lipscomb, 
1988). Most studies support the concept that AM are poor APC for 
priming T cells even when they express high levels of class I1 MHC, 
as human AM do (Holt, 1979; Ansfield et al., 1979; Toews et al., 1984a; 
Lipscomb et al., 1986). Bronchoalveolar cells, which contain up 
to 90% AM, fail to act as effective APC in vitro because they are 
either actively suppressive or because they fail to express some other 
poorly understood accessory function which may manifest as poor 
lymphocyte-accessory cell binding (Shellito et al., 1983; Lyons et al., 
1986; Kradin et al., 1987). Most current evidence indicates that DCs 
are the most efficient APC in stimulating naive T cells, especially CD4 
T cells, although class I1 MHC-positive cells of many cell types are 
capable of stimulating recently primed T cells (Steinman, 1991; Croft, 
1994). Variable contamination of cells with lung DCs (Pollard and 
Lipscomb, 1990) and the presence of recently activated T cells in 
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responder populations may well explain reports that AM can function 
as effective APC (Rich et al., 1987). 
Mechanisms utilized by populations of BAL cells to suppress im- 
mune responses are likely to depend on variables of the assay systems 
and are particularly dependent on animal species. In dogs, PGEz pro- 
duction (Demenkoff et d., 1980) and the synergistic activity of PGEz 
and oxygen radicals (Kaltreider et al., 1986) were shown to be im- 
portant. In humans, AM/lymphocyte contact leading to inhibition of 
receptor-induced intracellular calcium increases in responder T cells 
has been described (Yarbrough et al., 1991). Resident murine macro- 
phages, particularly at high numbers relative to numbers of stimulator 
lung DC, suppress a mixed lymphocyte reaction (MLR) by secreting 
TGFP (Lipscomb et al., 1993b). Furthermore, nitric oxide (NO) made 
by murine AM may inhibit the development of potent APC cell func- 
tion of lung DC (Holt et al., 1993). Evidence that AM suppression 
plays a role in vivo has been indirectly shown by depleting AM with 
an intratracheal dose of liposomes containing a macrophage cytotoxic 
drug (dichloromethylenediphosphonate) followed by immunizing via 
the respiratory tract. The animals demonstrated increased numbers 
of antibody-forming cells (AFCs) in LALNs compared to immunized 
controls pretreated with only liposomes (Thepen et al., 1989). IgG, 
IgA, and IgE AFCs were all increased. 
AM-suppressive activity is important to prevent the development 
ofhypersensitivity reactions, but in circumstances in which lungimmu- 
nity is important for protection, AM-suppressive activity could be 
counterproductive. However, suppressive activity of murine macro- 
phages can be inhibited by exposure to GM-CSF and to a lesser extent 
by other selected cytokines (Bilyk and Holt, 1993). The major role of 
AMs seems to be to phagocytose and remove potentially dangerous 
particulates and soluble antigens from the alveoli and to inhibit local 
lung immune responses. However, immunity may develop in the pres- 
ence of otherwise suppressive AMs by the recruitment of leukocytes 
to the alveolus with opposing activity or by strong environmental 
influences that result in cytokine secretion that diminishes AM suppres- 
sor function. 
C. LUNG DENDRITE CELLS 
Immunologists have long recognized that adherent cells are required 
for optimal in vitro immune responses whether one measures T 
cell lymphoproliferative responses, T cell cytokine production, or T- 
dependent B cell responses. They have also developed an increasing 
appreciation of the role of DCs in priming naive T cells since they 
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were first identified in the spleen (Steinman and Cohn, 1973). Since 
then, the role of DCs in immune responses initiated at the epithelial 
surface is being clarified. Little doubt exists that DCs play a pivotal 
role in initiating immune responses in the skin (reviewed by Steinman, 
1991). Furthermore, substantial support has developed for the concept 
that intraepithelial DCs are functionally different from those that have 
migrated into regional lymph nodes. Thus, freshly isolated Langerhans 
cells are capable of processing antigen and stimulating T cell clones, 
but they require “maturation” in vitro before they are fully effective 
in stimulating naive T cells in an MLR; at this time they have a 
markedly reduced capacity to process antigen (Romani et al., 1989). 
Data indicate that lung DCs share a number of characteristics of skin 
DCs and likely also play a critical role in initiating lung immunity 
(Holt, 1993). 
APCs must not only process antigen and express it in the context of 
class I1 MHC, but also express appropriate accessory molecules to 
enhance the interaction of the APCs with T cells. Recent studies em- 
phasize the importance of the interaction of €37 on the APC cell surface 
with CD28 and/or CTLA4 expressed on responder T cells to deliver 
a second signal (reviewed by June et al., 1994). Failure to trigger this 
second signal may cause T cells interacting with APCs via only the 
TCR-peptide/MHC I1 interface to become anergic (Harding et al., 
1992; Boussiotis et al., 1993; Chen and Nabavi, 1994) and produce a 
state of tolerance in oivo (Van Goo1 et al., 1994). B7 is a receptor family 
of at least two molecules in the immunoglobulin supergene family. 
B7-1, (CD80), and B7-2 (CD86) are both expressed constituitively on 
DCs in contrast to macrophages and B cells that must be activated to 
express these molecules (Vandenberghe et al., 1993). Other important 
accessory molecules, usually identified phenotypically by standard 
immunocytochemistry and functionally by the ability of specific anti- 
bodies to block an immune function, include CD40, CD54 (ICAM-l), 
and CD58 (LFA-3) (Steinman, 1991). 
1 .  Isolation and Characterization 
Like DC from other sites, lung DC constituitively express both 
class I and I1 MHC, are light density, loosely adherent, poorly or 
nonphagocytic, and demonstrate long dendritic processes both in tis- 
sue sections and in cell suspensions (Holt et al., 1985;1988; Sertl et al., 
1986; Rochester et al., 1988; Nicod et al., 1987; Pollard and Lipscomb, 
1990). Lung DCs fail to express pan T, natural killer (NK) cell, B 
cell and many macrophage markers. The critical accessory molecules 
CD54 and CD58 (Xia et al., 1991; Nicod and El Habre, 1992) are 
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present on many lung DCs, but data are incomplete on the expression 
of CD40, CD80, and CD86 family. 
The high levels of constitutive class I1 MHC and the dendritic shape 
of DCs has been exploited to examine their location in tissue sections 
of lung by a number of investigators. DCs form an interdigitating 
network in the airway epithelium of all species in whom they have 
been investigated (Sertl et al., 1986; Holt, 1993) similar to the network 
described for skin Langerhans cells. Intraepithelial DCs are particu- 
larly dense in the trachea and gradually diminish in concentration as 
the airways branch, but are increased at sites of chronic inflammation 
(Schon-Hegrad et al., 1991). DCs also exist in the connective tissue 
surrounding bronchi and bronchioles, in perivascular connective tis- 
sue, in alveolar septa, in the pleura, and in very small numbers in 
alveolar spaces (Sertl et al., 1986; Holt and Schon-Hegrad, 1987; 
Kradin et al., 1991; Havenith et al., 1992; van Haarst et al., 1994). 
In rats, intraperitoneal injections of IFNy increased the numbers of 
intraepithelial and septa1 DCs without increasing their accessory cell 
function (Kradin et al., 1991), and inoculation of Bacillus Cal- 
mette-Guerin (BCG) increased the numbers of DC that could be la- 
vaged from the alveolus (Havenith et d., 1992). Thus, the numbers of 
lung DCs in various anatomic sites depend on signals delivered that 
are coincident with inflammation. 
Lung DCs have been isolated with a variable degree of success 
utilizing adherence, density, and class I1 MHC expression properties; 
their function and other phenotypic features have been studied. Lung 
macrophages are the most difficult cells to separate from DCs in single 
cell suspensions of lung cells. Effective procedures for isolating fairly 
pure DC populations require exploiting the phagocytic and autofluore- 
scent properties of lung macrophages (Nicod et al., 1987,1989a; Pollard 
and Lipscomb, 1990; Havenith et al., 1993a). Using these techniques, 
the function of DC-enriched lung cells has been assessed. Functional 
assays have included stimulation of periodate-treated lymphocytes, 
MLRs, and antigen-induced stimulation of either memory T cells or 
lymphoblasts. All have shown that lung DCs function as well or better 
than DCs from other sources (Nicod et al., 1987; Rochester et al., 1988; 
Pollard and Lipscomb, 1990). 
2. Phenotypic Heterogeneity 
DCs isolated from whole lung preparations are phenotypically het- 
erogeneous, and cell markers differ somewhat among animal species 
and even within individuals of a species. An example of this latter 
variation relates to CDla (OKT6), expressed by human Langerhans 
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cells in the skin, which has been variously described as being present 
on from less than 1% (Sertl et al., 1986; Nicod et al., 1987) to 30% 
(van Haarst et al., 1994) of lung DCs in man. This antigen may be 
important in stimulating y6 T cells, a potentially important interaction 
for host defenses in the lung in view of observations that y6 T cells may 
recognize heat-shock proteins of Mycobacterium tuberculosis (Mtb) 
(Born et al., 1991, Kaufmann and Kabelitz, 1991). 
Variation in expression of cytoplasmic and surface markers also oc- 
curs within populations of lung DCs. For example, in the mouse, the 
interdigitating cell antigen (NLDC-145) and CR3 are present on about 
half of lung DCs, while the majority of lung DCs express CD25 and 
the heat-stable antigen (as defined by J11D; Pollard and Lipscomb, 
1990). The latter two markers are also uniformly expressed on murine 
thymus and skin DCs, but are absent from the majority of splenic DCs 
(Crowley et al., 1989), indicating the likelihood of a closer relationship 
of lung DCs to tissue DCs rather than to DCs that primarily home 
from bone marrow to lymphoid tissue. Additional evidence that lung 
DCs are distinct from the majority of splenic DCs is that lung DCs 
fail to express the splenic DC marker recognized by the monoclonal 
antibody 33D1 (Pollard and Lipscomb, 1990). 
In both rat and mouse, another heterogeneous marker is FcRII, 
positive on about half of lung DCs (Pollard and Lipscomb, 1990; Xia 
et al., 1991). Interestingly, Langerhans cells freshly isolated from the 
skin express FcRII which is downregulated as the cells mature in 
culture. Thus, it is possible that the FcR expression in the lung denotes 
a population similar to freshly isolated skin DCs. In the rat, DCs in 
the epithelium lining the airways are more likely to be FcR+ , whereas 
parenchymal DCs are nearly uniformly FcR- (Gong et al., 1992). Mu- 
rine DC in the epithelium of the trachea also express FcRII (Sertl et 
al., 1986). This suggests the possibility that intraepithelial DCs are 
poised to take up and process antigens at the epithelial/environment 
interface and enter the interstitium to traffic to LALN. Thus, at least 
some interstitial DCs which fail to express FcR may be in transit. 
On the other hand, the presence of FcR- DCs in lung parenchyma, 
including alveolar septa, may indicate distinct immune functions for 
this subset of lung DCs. 
No difference was found in mice in the capacity of the FcR+ or 
FcR- subsets to stimulate an MLR (Pollard and Lipscomb, 1990). 
However, in the rat, the FcR- population was a more potent stimulator 
of naive T cells in an MLR and in responses to lectins, but FcR- 
and FcR+ were equally capable of presenting soluble and particulate 
antigens to antigen-sensitized T cells (Kradin et al., 1993). Of interest 
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in these later studies was that 70% of FcR- and only 39% of FcR+ 
cells expressed the adhesion molecule CD54 (Kradin et al., 1993), an 
observation that might partly explain the increased ability of the FcR- 
cells to stimulate an MLR. In elegant studies in which lung intraepithel- 
ial DCs were isolated from the rat, these cells were shown to present 
antigen to primed T cells more efficiently than did parenchymal DCs. 
In man, further enrichment for FcR+ decreased the ability of lung 
cells enriched in DC to stimulate an MLR (Nicod et al., 1987), although 
these studies are complicated by the large numbers of contaminating 
FcR+ macrophages in the DC populations. Nevertheless, FcR positi- 
vity has been a useful marker for identifying subsets of lung DCs 
and the majority of data are consistent with the concept derived from 
Langerhans cells that a population of FcR+ intraepithelial DCs may 
take up antigen from the bronchial lumen and differentiate into cells 
that can stimulate naive T cells upon migration into draining lymph 
nodes. 
3. Origin 
DCs in all tissue sites originate from the bone marrow (Steinman, 
1991). They can be cultured from precursors in bone marrow and 
peripheral blood using GM-CSF and, for adult human DCs, from pe- 
ripheral blood with IL4 (Inaba et al., 1992,1993; Thomas et al., 1993; 
Sallusto and Lanzavecchia, 1994). In one study, Ia+ lung DCs were first 
recognized in rat lung parenchyma in fetal life at Day 15 of gestation 
(McCarthy et al., 1992). Intraepithelial DCs were present by Day 17 
and continued to increase during postnatal development (McCarthy 
et al., 1992). Comparison of fetal lung DCs demonstrated that they 
were not as efficient as adult DCs in stimulating an immune response, 
but were fully functional at birth. In contrast, another study failed to 
detect Ia+ DCs in rat lung epithelium or parenchyma until birth, and 
the numbers increased rapidly until 3 weeks of age when they approxi- 
mated those found in adults (Nelson et al., 1994). Ia+ DCs were first 
observed in the nasal turbinates and intensity of Ia staining increased 
in time, first in the trachea and later in lung parenchyma, compatible 
with environmental exposure effecting the change. Using another 
marker for DC, OX62 (which also detects y6 T cells), these same 
authors found CD3-negative, 0x62-positive DCs at all levels of the 
lung in fetal rat lung and speculated that environmental influences 
upregulated Ia expression and subsequent function of these cells. 
Consistent with this speculation was that IFNy increased the numbers 
of la+ cells in airway epithelium while steroid inhalation decreased 
the numbers relative to control rats. The conflicting findings of the 
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two groups may be based on the differences in the housing environ- 
ments for the two groups of rats. Thus, Nelson and collaborators (1994) 
used dust-free bedding in contrast to McCarthy et al. (1992). It was 
quite likely that in utero influences affected the numbers and function 
of lung DCs. 
4 .  In Viuo Function 
Numerous studies have demonstrated that DCs from spleen, lymph 
node, and skin have extraordinarily potent ability to immunize recipi- 
ent animals following inoculation either iv or subcutaneously (Knight 
et al., 1983; McKinney and Streilein, 1989; Sornasse et al., 1992). Lung 
DCs have not been used to immunize experimental animals to date, 
but several lines of evidence suggest that they have an important role 
in uiuo. As discussed, their location within the epithelium places them 
in an optimal position to take up and process antigens that breach the 
epithelial barrier; perivascular and septa1 DCs should be poised to 
process antigens that reach the lung via the vasculature. Studies have 
shown that splenic DCs instilled into the lung may reach LALN (Ha- 
venith et ul., 1993b) and if pulsed with antigen may induce an immune 
response (Havenith et al., 1993~).  In this latter study, AMs pulsed 
with antigen were also capable of initiating an immune response, 
but in contrast to DCs heat-killed AMs were also able to immunize 
suggesting that AMs stimulated responses by having the antigen reproc- 
essed by the host’s own APCs. Additionally, explanted lung DCs had 
gained the ability to stimulate primed T cells following the intratra- 
cheal delivery of the relevant antigens (Holt et al., 1993). Last, consis- 
tent with the dynamic activity of epithelial DCs in carrying environ- 
mental antigens into LALN, irradiation of rats resulted in a loss of 
85% of resident DCs by 72 hr and reconstitution of tracheal DCs from 
bone marrow precursors by 10 days (Holt et al., 1994). Lung DCs most 
surely play a major role in regulating lung immunity and, as discussed 
previously, are likely themselves regulated by multiple environmental 
factors. It remains to be determine whether antigen presented by lung 
DCs is more likely to result in TH1 versus Th2 responses in the lungs 
and whether bypass of DCs in immunization of the host is more likely 
to deliver a tolerogenic signal, or whether other factors are more im- 
portant in determining these outcomes. 
D. LUNG LYMPHOCYTES 
T cells, B cells, and NK cells have all be described in various lung 
compartments (Holt and Schon-Hegrad, 1987; Stein-Streilein, 1988; 
Pabst, 1990; Agostini et al., 1993). Their phenotype and function have 
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been described either by evaluating markers in situ or by obtaining 
cells from BAL or collagenase digestion of lung tissue. As with lung 
macrophages and DCs, lung lymphocytes are a dynamic population 
with the capacity to enter and leave the lung depending on influences 
in the milieu. 
1 .  Location 
In several species including rat, rabbit, and chicken, large numbers 
of lymphocytes are located in organized bronchus-associated lymphoid 
tissue (BALT), which is discussed below. However, BALT is not consti- 
tutive in all species and not regularly seen in hamsters, mice, and 
humans. In these latter species, the majority of lung lymphocytes are 
present in the interstitiurn, diffusely scattered in the mucosa, alveolar 
septa, or pleura. Also, depending on the species, there may be an 
intraepithelial and/or an intravascular pool of lymphocytes (Pabst, 
1990). A population of lung lymphocytes exists in the bronchoalveolar 
spaces and is recovered by BAL. In animals kept in specific pathogen- 
free environments, lymphocytes range from 5 to 10% of cells recovered 
by BAL (Agostini et al., 1993; Pabst, 1990). In normal, nonsmoking 
humans the figures vary from less than 8 to 20% (Daniele et al., 1975; 
Davidson et al., 1985; Becker et al., 1990). 
The proportion of T cells to B cells and NK cells varies to some 
degree with the compartment in which the lymphocytes are present. 
The composition of lymphocytes in BAL fluids is generally representa- 
tive of the proportion of T cells, including CD4 and CD8 T cells, and 
B cells found in peripheral blood. Interestingly, in humans, differences 
in the phenotype and function of NK cells occur between the periph- 
eral blood and the alveolus. Thus, NK cells in human alveoli fail to 
express cytolytic activity and are largely negative for CD16, although 
CD16-expressng NK cells with cytolytic activity exist in the intersti- 
tium (Weissler et al., 1987). Relatively high numbers of cytolytically 
active NK cells also exist in the interstitium of mice. Fifteen to 20% 
of cells fractionated on nylon wool columns following isolation from 
enzyme-digested lungs express the allotypic NK1.1 marker, detectable 
in C57BU6 mice (Stein-Streilein et al., 1983). 
When leukocytes are isolated from the lung parenchyma of guinea 
pigs, mice, rats, and humans, the relative percentage of lymphocytes 
varies from 15 to over 50%. The variance likely depends on the strain 
of animal, whether they are kept specifically pathogen-free, and the 
rigor by which small monocytes are excluded (much of the data are 
derived from examining Wright-Giemsa-stained cytospin prepara- 
tions) (Lipscomb et al., 1982; Stein-Streilein et al., 1983; Holt and 
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Schon-Hegrad, 1987; Nicod et al., 1989a,b). Flow cytometric analysis 
of T cell and B cell populations of lung lymphocytes indicates that 
the relative proportion of B cells is either increased or the same, 
and the CD4/CD8 ratios are either decreased or similar compared to 
peripheral blood (Holt et al., 1986; Abraham et al., 1990; Marathias 
et aZ., 1991; Huffnagle et al., 1994). 
Intraepithelial lymphocytes are common in the gut mucosa and exist 
in lung epithelium of some animal species, but are relatively less 
common than those in the gut (Holt and Schon-Hegrad, 1987; Fournier 
et al., 1989). In humans, no B cells were found in airway epithelium, 
and CD8 outnumbered CD4 T cells (Fournier et al., 1989). In an 
examination of epithelium of the upper respiratory tract (in the nose 
and covering the tonsil and adenoids), both B cells and T cells were 
found. Notably, y6 T cells occurred in aggregates where they com- 
prised up to 30% of the total T cells, although in general 80-90% of 
T cells expressed the Cup TCR (Graeme-Cook et al., 1993). 
In studies examining cells isolated from human lung parenchyma, 
y6 T cells made up less than 5% of T cells and were CD3+, CD4-, 
and CD8- (Abraham et al., 1990; Marathias et al., 1991). In a study of 
mice, on the other hand, 8-20% of resident lung lymphocytes were 
CD3+ and ap TCR-, and were presumably y6 T cells. y6 T cells 
increased following aerosol delivery of M .  tuberculosis (Augustin et 
al., 1989). 
2.  Traffic 
The regulation of movement of lymphocytes into and out of the 
lung is still incompletely understood. Nevertheless, with increased 
information about the role of adhesion molecules in regulating the 
traffic of lymphocytes (Springer, 1994), investigators are beginning to 
unravel what regulates steady-state movement of cells into the lung 
as well as possible preemptive signals that occur with inflammation. 
Research on emigration of cells into the lung has centered on the 
accumulation of neutrophils within pulmomary vasculature and their 
immigration into the air spaces of the lung because these cells are 
likely to play a critical role in the development of the acute respiratory 
distress syndrome. Recent information indicates that the adhesion mol- 
ecules, P- and E-selectin, the integrins, and ICAM-1 and ICAM-2 
play important roles in the accumulation of neutrophils in the lung 
(Pilewski and Albelda, 1993), The relevance of each adhesion mole- 
cule likely depends on the inflammatory stimulus that provokes the 
recruitment (Hellewell et al., 1994; Doerschuk et aZ., 1990; Doerschuk, 
1992; Mulligan et al., 1993a-e). 
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The regulation of lymphocytes into the lungs is less well understood 
even though, as mentioned above, evidence exists that lymphocytes 
isolated from LALN or collected from the efferent lymphatics of LALN 
have a predisposition to return to the lungs (McDermott and Bienens- 
tock, 1979; Spencer and Hall, 1984; Joel and Chanana, 1987). Several 
studies have demonstrated that T lymphocytes isolated from lung la- 
vages of normal humans predominantly express a memory phenotype, 
e.g., they are CD45RO+, CD45RA- cells (Saltini et al., 1990; Becker 
et al., 1990). Other important markers for naive versus memory T cells 
are the hyaluronic acid receptor (CD44) and L-selectin. Naive T cells 
express low levels of CD44 and high levels of L-selectin, memory T 
cells express high levels of CD44 and low levels of L-selectin (re- 
viewed in Sprent, 1994). Thus, with the recognition that memory T 
cells accumulate preferentially in the lung, the issue becomes what 
is the stimulus for their entry and why do naive cells fail to accumulate. 
The role of naive T cells with their multitude of diverse receptors 
is to continuously recirculate through secondary lymphoid organs, i.e., 
spleen and lymph nodes, so that antigen-bearing APCs can interact 
with appropriate T cells at that site. This APC-T cell interaction results 
in clonal expansion and subsequently provides challenged tissues with 
a population of cells able to specifically react and protect the host. 
Thus, naive T cells have receptors that allow them to migrate to second- 
ary lymphoid organs (Butcher et al., 1990; Jutila 1994). In contrast, 
lymphocytes that must enter challenged or inflamed tissues might be 
expected to express a different set of homing receptors. Indeed, this 
is the case. Although accumulation in markedly inflamed sites seems 
to be nonspecific, when only low levels of inflammation exist, where 
immune cells accumulate may be determined in the draining lymph 
nodes from which they derive (Picker, 1994). Teleologically, this 
would be a more efficient way for the immune system to selectively 
redirect cells to sites where they are needed. Indeed, evidence 
suggests memory lymphocytes bearing the cutaneous lymphocyte- 
associated antigen seem to specifically home to the skin (reviewed in 
Picker, 1994). Studies also suggest that memory cells in the lung may 
have a unique set of homing receptors compared to memory cells in 
the skin or at mucosal sites (Picker et al., 1994). Thus, CD3+, CD45RO 
high/CD45RA low T cells in the skin were E-selectin+ and CLA+, but 
were a4p7- and aefi7-, while lung memory T cells were E-selectin-, 
CLA-, and a4P7-, but 50% of the cells were aep7-. The lung phenotype 
was different from the overall memory T cell phenotype in blood, 
suggesting that there might be an unidentified receptor on lung T 
cells that specifically selected them for emigration into the lung. 
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An important issue is whether any naive lymphocytes traffic through 
the lungs. Naive T cells migrate into peripheral lymph nodes via high 
endothelial venules (HEV) using an L-selectin/peripheral lymph node 
addressin interaction. Some animal species have BALT in which HEV 
are present. Thus, in these animals, naive cells could enter the lungs 
and be available for primary immune responses to develop at these 
sites. However, evidence to support this possibility does not exist. 
Despite scanty information about the migration of naive and long-term 
memory T and B cells into the lungs, several studies have noted that 
lymphoblasts (or recently divided lymphocytes) have a tendency to 
migrate into both inflamed and uninflamed lung (Daniele et aZ., 1977; 
Berman et al., 1990). The location and mechanisms of lymphocyte 
transmigration are under investigation. 
E. ORGANIZED BALT 
Macrophages, DCs, and lymphocytes are diffusely distributed 
throughout all of the compartments of the lung. In addition, in most 
animal species examined, at least some organized lymphoid tissue 
may be found in variable amounts lining bronchi and bronchioles. 
These structures have been recognized for many years, but were first 
carefully described in 1973 (Bienenstock et al., 1973a,b). More re- 
cently, some controversy about these structures has been raised be- 
cause of the inability to readily detect them in all species. Thus, 
they are relatively rare in normal humans, cats, and young pigs (Pabst, 
1990,1992). When first described they were compared to intestinal 
Peyers patches; they had the appearance of a follicle without a capsule. 
Furthermore, lymphocytes infiltrates the overlying bronchial epithe- 
lium which demonstrated alterations in morphology compared to adja- 
cent epithelial cells. They were originally described in the bronchial 
mucosa of all species examined, e.g., rabbits, guinea pigs, rats, mice, 
dogs, pigs, chickens, and man (Bienenstock et al., 1973a). These early 
studies revealed that neonatal thymectomy failed to affect the normal 
development of BALT in rats and chicks, and that tritiated thymidine 
labeling and autoradiography indicated that there was rapid cell prolif- 
eration of cells constituting BALT (Bienenstock et al., 1973b). Trans- 
plantation of fetal lungs into extrapulmonary sites did not interrupt 
the development of the BALT, although it was not as cellular, sug- 
gesting that antigenic stimulation was required for full development. 
Since these early studies, two comprehensive reviews have summa- 
rized the morphology and function of BALT (McDermott et al., 1982; 
Sminia et al., 1989). An individual aggregate of BALT or bronchus- 
associated lymphoid unit (BALU), a term defined by Sminia and col- 
386 MARY F. LIPSCOMB ET AL. 
leagues, consists of a focal area of T and B cells admixed with fibro- 
blasts, reticulum cells, macrophages, interdigitating cells which are 
comparable to Ia-positive DCs, and follicular dendritic cells. BALUs 
have no capsule, subcapsular sinuses, nor afferent lymphatics. Never- 
theless, they have peripheral sinus-like lymphatics which subse- 
quently drain into lymph nodes (Lauweryns and Baert, 1976-1977). 
Furthermore, there are arterioles, capillaries, and venules which in- 
clude high endothelical venules (HEV) (Otsuki et al., 1989). The struc- 
ture of a BALU with the demonstration of HEV indicates the likelihood 
that naive T cells might migrate to these structures and initiate a 
primary immune response against an antigen translocated from the 
bronchial lumen, comparable to the role for Peyers Patches in the gut. 
Although early studies failed to demonstrate antigen could cross the 
overlying epithelium, more recent studies have suggested that soluble 
antigens might be translocated from the bronchial lumen across the 
epithelium overlying a BALU (Fournier et al., 1977; Myrvik and Ock- 
ers, 1982; van der Brugge-Gamelkoorn et al., 1985). 
In BALUs lymphocytes are partitioned into B and T cell areas with 
central B cells surrounded by T cells. The dome over these areas and 
underneath the epithelium is a mixture of B and T cells (Sminia et al., 
1989). In BALUs, IgM- and IgG-bearing cells are present in significant 
numbers together with IgA-positive cells which contrasts with Peyers 
Patches in which IgA cells predominate (Sminia et al., 1989). In rats, 
BALT has been examined with monoclonal antibodies to determine 
the type of T cells present; CDCpositive cells outnumber CD8- 
positive cells, but in the B cells aggregates nearly all of the T cells 
are CDCpositive cells (Sminia et al., 1989). 
Important studies relating to the traffic of T and B cells to BALUs 
have been published (van der Brugge-Gamelkoorn and Kraal, 1985) 
demonstrating in vitro binding of equal numbers of T and B lympho- 
cytes to both rat and guinea pig BALUs. This finding is clearly different 
from Peyers Patch binding of T and B cells in which the numbers of 
B cells that bind are much greater than T cells that bind at a ratio of 
five B cells for every T cell (Stevens et al., 1982). This finding corre- 
sponds to the increase in B cells in Peyers patches relative to the 
numbers of B cells in BALUs (Crawford and Miller, 1984). Taken 
together, these studies indicate that the specificity of HEV in BALUs 
is different from that in Peyers patches and more closely resembles 
the specificity of the HEV in mesenteric lymph nodes (van der Brugge- 
Gamelkoorn and Kraal, 1985). 
It is important to address the issue of a similarity of BALT with gut- 
associated lymphoid tissue. BALT is prominent in certain species 
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including chicken, rabbit, and rat, but is clearly much less prominent 
in other species, including man. In some members of these species, 
BALT may be completely absent (Pabst, 1990). Nevertheless, even in 
man, other studies have shown that after birth, there is a gradual 
increase in loose aggregates of lymphoid cells that collect beneath the 
epithelium, particularly at points of bifurcation of bronchi. In man, 
mouse, and hamsters, these collections of lymphoid cells do not in- 
volve the epithelium nor modify the epithelium over the aggregate. 
In view of the relative lack of prominence of these structures in certain 
species, it suggests that their role in protective immune responses in 
the lung is not essential. Since an important function in the gut is for 
these structures to initiate IgA responses, it is possible that the lack 
of well-organized BALT in some species predicts that local initiation 
of IgA responses is not required for health. It also suggests that the 
common mucosal system in which IgA B cell precursors are developed 
in the gut and migrate to the lung may function to successfully protect 
the host from lung infections. 
111. lung Immunity to Noninfectious Particulate and Soluble Antigens 
Since the late 1960s, investigators have been systematically explor- 
ing mechanisms in the development of immune responses to particu- 
late and soluble protein antigens in the lung (Pepys, 1969). A major 
impetus was to understand what caused hypersensitivity lung diseases, 
such as asthma and hypersensitivity pneumonitis, to develop in some 
individuals, but not in others, although antigenic exposures were the 
same. Models to examine immune responses to various respiratory 
antigens were developed in many animal strains, including mice, rats, 
hamsters, guinea pigs, ferrets, dogs, monkeys, horses, and cattle; anti- 
gens were delivered via aerosol, intranasal, intratracheal, or intrabron- 
chial instillation. The end point for immunity in experimental animals 
was generally measured by assessing the development of hypersensi- 
tivity disease clinically and morphologically, measuring serum and/ 
or bronchoalveolar antibody, or characterizing some aspect of cell- 
mediated immunity (CMI) such as migration inhibition, delayed-type 
hypersensitivity (DTH) via skin test, or lymphoproliferation (Richer- 
son, 1972; Newhouse et al., 1976; Kaltreider, 1976; Kazmierowski et 
al., 1977; Ganguly and Waldman, 1977). 
Among the important findings of these early studies were that solu- 
ble antigens instilled into the lungs, in contrast to particulate antigens, 
often failed to produce immunologic lung damage (Schatz et al., 1977; 
Fink, 1988), and that soluble antigen repeatedly instilled into the lung 
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could lead to local tolerance (Ratzjczak et al., 1980; Holt and Leivers, 
1982). Interpretation of early studies did not benefit from the current 
perspective that the type of immune response that develops, i.e., CMI 
versus antibody (including the predominant isotype of the antibody), 
is regulated by cytokines secreted by T cells and other cells present 
at sites of antigen deposition (Mosmann and Coffman, 1989). More 
recent studies have expanded the important concepts derived from 
earlier studies by focusing on the regulatory mechanisms in the devel- 
opment of lung immunity. 
In order to understand how various forms of antigen might reach 
the immune apparatus and, therefore, antigen clearance is discussed. 
Then, while T and B cell immunity are clearly interdependent, studies 
that have focused on measuring specific T cell responses versus immu- 
noglobulin synthesis in response to noninfectious lung antigens are 
summarized. Models that specifically examine the lung’s response to 
infectious agents and alloantigens or lead to hypersensitivity disease 
are covered later. 
A. LUNG CLEARANCE OF ANTIGENS 
Many studies have shown that the LALNs are responsible for pri- 
mary immune responses after lung immunization (Bice et al., 1980b; 
Kaltreider et al., 1983; Stein-Streilein et al., 1979; Stein-Streilein and 
Hart, 1980; Lipscomb et al., 1982). LALNs function as effective filters 
to remove particulate materials cleared from the lower respiratory tract 
via the lymphatics (Brain et aZ., 1978; Green et al., 1977; Morrow, 
1972). Although LALNs are largely responsible for the induction of 
immunity after primary immunization, the mechanisms responsible 
for the clearance of antigen from the lung to LALNs are not completely 
understood. Most antigen deposited in the lung is cleared by phagocy- 
tosis by AMs and neutrophils that transport foreign material up the 
mucociliary escalator and out of the lung, although some antigen is 
transported to LALNs where an immune response is produced. At 
least some of this latter antigen is carried free in lymphatic fluid and 
apparently occurs in circumstances of limited inflammation (Lauwer- 
yns and Baert, 1976-1977). 
The induction of pulmonary inflammation by antigen exposure ap- 
pears particularly important in the translocation of immunogens from 
the lung to LALNs. Exposure of the lung to noninflammatory doses 
of antigen often fails to induce immune responses (Yoshizawa et al., 
1982; Bice et al., 1991). It is possible that an immune response to 
airway antigens requires a dose that overwhelms normal phagocytic 
and clearance mechanisms (Bice and Muggenburg, 1988; Bice et al., 
1991). The observation that elevated immune responses are produced 
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in LALNs if antigen is deposited in the lungs of animals that have 
inhaled inflammagens further supports the importance of pulmonary 
inflammation in the translocation of antigen from the lung to the 
LALNs (Bice et al., 1985,198713). It is possible that inflammation may 
also alter the relative proportion of antigen reaching LALNs in cells 
as opposed to antigen free in lymphatic fluid. 
In dogs inoculated via the airways with sheep red cells, a large 
number of neutrophils enter the lung from the vasculature with a peak 
response about 1 day after instillation of antigen (Bice et al., 1989). 
Furthermore, neutrophils can phagocytize particles in the alveoli and 
migrate to the LALNs carrying the particles (Harmsen et al., 1987). 
AMs can also phagocytize particles in the lung and transport them 
to LALNs (Corry et al., 1984; Harmsen et al., 1985). The relative 
contribution of neutrophils and AM in the translocation of antigen 
from the lung to LALNs is not known. However, neutrophils with 
phagocytized particles reach LALNs earlier than AMs and, may be 
more important for antigen transport to LALNs than AMs. Antigen 
transported to the LALNs may be released from both neutrophils and 
AMs and reprocessed by resident APCs to initiate pulmonary immu- 
nity. In addition to AMs and neutrophils, as previously discussed, lung 
DCs also likely carry antigen to the LALNs, and recent studies in 
which pulsed splenic DCs inoculated into the trachea were capable 
of immunizing the hosts supports this concept (Havenith et al., 1993~).  
Whether antigen or lung DC initiates a different type of T helper 
subset response than antigen arriving in phagocytes or free in lymph 
has not been determined. Nevertheless, if lung inflammation enhances 
the transport of antigens from the lung to the LALNs, it is possible 
that inhalation of materials that induce pulmonary inflammation might 
lead to increased recognition of airborne antigens. Thus, pulmonary 
inflammation caused by inhaled pollutants (Osebold et al., 1980) and 
passive cigarette smoke (Murray and Morrison, 1988; Ehrlich et al., 
1992) might increase the immune recognition of allergens and be 
responsible for increasing rates of asthma (Evans et al., 1987; Platts- 
Mills et al., 1991). In addition, inflammation induced by pulmonary 
viral infections may also be important in the induction of immunity 
to low levels of environmental antigens, e.g., allergens responsible 
for asthma (Castleman et al., 1990; Duff et al., 1993). 
B. T CELL-MEDIATED LUNG IMMUNITY 
Several important questions relate to the development of CMI in 
the lung and include (1) do antigens instilled into the lung cause 
local and/or systemic CMI? (2) Does the form of antigen, i.e., soluble, 
particulate, expressed by viable microorganisms influence the out- 
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come? (3) Does iv or subcutaneous inoculation of similar antigens 
generate similar degrees of CMI in the lung? (4) What redirects the 
immune T cells back into the lungs? 
Inoculation of antigens into the lung can result in both local and 
systemic CMI (Kaltreider, 1976). As discussed previously, both soluble 
and particulate antigens can induce immunity, but soluble antigens 
induce a less easily detectable CMI response than a similar antigen 
delivered in particulate form as shown by experiments in which either 
soluble or aggregated human serum albumin were used as the immuno- 
gen (Burrell and Hill, 1975; Hill and Burrell, 1979). Infectious organ- 
isms which replicate in situ are even more capable of producing CMI 
both locally and systemically (Waldman et al., 1972; Spencer et al., 
1974; Ganguly and Waldman, 1972; Lipscomb et al., 1982). Haptens, 
such as trinitrobenzene (Stein-Streilein, 1983), or metals (Parker and 
Turk, 1978), such as beryllium oxide (Haley et al., 1989), may also 
induce CMI in the lung following direct instillation into appropriate 
animal models. Haptens and metals are agents that lead to sensitization 
of humans exposed to these agents in the workplace and are associated 
with hypersensitivity reactions. 
A number of early studies addressed the issue of whether subcutane- 
ous, iv, or direct lung instillation of antigens resulted in differences 
in the expression of CMI. In three separate studies, guinea pigs in- 
jected via the lung with human y-globulin (HGG), DNP-HGG, or heat- 
killed influenza virus accumulated specific T cells among lymphocytes 
recovered from the lungs as measured by migration inhibition factor 
release or by antigen-induced lymphoproliferation assays. However, 
subcutaneous or iv injection of these antigens failed to result in measur- 
able specific T cell accumulation in the lungs, although systemic CMI 
could be measured in lymphocytes from nodes draining the subcutane- 
ous inoculation site or from spleen (Waldman and Henney, 1971; Nash 
and Holle, 1973; Lipscomb et al., 1982). However, the initiation of a 
mild inflammatory response in the lungs resulted in the accumulation 
of immune T cells in the lungs of the animals immunized via the 
extrapulmonary route (Waldman et al., 1972; Nash and Holle, 1973; 
Lipscomb et al., 1982). 
Using a live, attenuated rubella vaccine or another live strain of 
rubella virus, the kinetics of a local CMI response was studied follow- 
ing the inoculation of guinea pigs either subcutaneously or by an 
intranasal inoculation (Morag et al., 1974). In these studies, migration 
inhibition factor activity was the parameter for measuring CMI re- 
sponses and was initially detected in the lungs 2 weeks after immuniza- 
tion, peaked at 4 weeks, but was no longer detectable by 6 weeks. 
When primary immune responses are generated in the LALN, what 
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stimulus recruits cells back to the lungs? Lymphoblasts rapidly exit 
lymph nodes during developing immune responses (Joel and Cha- 
nana, 1987). These cells enter the circulation and, under the control 
of adhesion molecules and locally generated chemotactic and other 
adhesion molecule-stimulating cytokines, are recruited into inflamed 
lungs (Berman et al., 1990). As previously discussed, although mark- 
edly inflamed lungs nonspecifically recruit both T cells and B cells, 
memory T cells generated in LALNs may also have homing molecules 
that specifically direct their return to the lung (Picker et al., 1994). An 
important factor in retaining recruited immune-specific cells is the 
continued presence of specific antigens within tissue and at least two 
groups have shown that this can occur (Lipscomb et al., 1982,1983; 
Lyons and Lipscomb, 1983; Emeson et al., 1982). Thus, T cell blasts 
enriched for two different antigens and labeled with two distinguish- 
able radioisotopes were shown to be retained in lung lobes nonspecifi- 
cally, but with an additional selectivity in lung lobes containing the 
relevant antigen (Lipscomb et al., 1982). Selective retention was in- 
duced by antigen carried by APC deposited in the lungs and was class 
I1 MHC restricted, suggesting that the T cells were retained in the 
lung lobes by binding to the APC in vivo (Lyons and Lipscomb, 1983). 
These studies added validity to a concept that four general mechanisms 
relate to recruitment and retention of immune cells in the lungs: 
(1) recently activated T and B cells, i.e., lymphoblasts, from any 
lymphoid tissue are nonspecifically recruited into inflamed lungs; 
(2) cells recently activated in LALNs express adhesion molecules that 
are uniquely designed to target their binding to lung endothelium; 
(3) matrix and lung parenchymal cell adhesion molecules expressed 
under the control of local environmental perturbations facilitate the 
emigration of immune cells; and (4) antigen expressed on the appro- 
priate MHC in the lung leads to preferential retention and further 
expansion in the lung. Specificity of recruitment for B cells has not 
been shown (see below), but in the presence of retained antigen and 
specific T helper cell recruitment, specific B cells could divide and 
differentiate. 
C. B CELL-DEPENDENT LUNG IMMUNITY 
1 .  Primary lmmune Responses 
Antigen-specific antibody produced in LALNs after a primary lung 
immunization is released into blood (Bice et aZ., 1980a; Shopp and 
Bice, 1987). In addition, large numbers of antigen-specific IgG, IgA, 
and IgM AFCs produced in LALNs also enter the blood after lung 
immunization of sevral species, e.g., dogs, cynomolgus monkeys, chim- 
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panzees, humans (Bice et al., 1980aJ982b; Kaltreider et al., 1981; 
Mason et al., 1985; Weissman et al., 1994). In studies of larger animals, 
AFCs in blood are recruited into a lung lobe exposed to antigen, but 
significantly fewer AFCs are found in the other lung lobes of the same 
animal that are exposed to saline or nothing. 
There appear to be two factors that control the entry of AFCs into 
the lung. First, AFCs must have been recently produced in an immune 
response (Bice et al., 1989). The lymphoid tissue in which they are 
produced exerts no control on their entry into the lung because AFCs 
produced in the popliteal lymph nodes enter the lung at the same rate 
as AFCs produced in LALNs (Hillam et al., 1985). Second, AFCs enter 
sites of inflammation produced by instillation of antigen into the lung 
(Bice et al., 1982a; Hillam et al., 1985). However, the recruitment of 
AFCs into inflammatory sites in the lung is not antigen specific because 
they also enter lung lobes inflamed by instillation of particles or other 
inflammatory agents. 
Plasma cells are found in the alveoli and interstitial lung tissues of 
immunized lung lobes suggestig that AFCs that enter the lung mature 
to plasma cells (Bice et al., 1987a). Most antigen-specific IgM, IgG, 
and IgA antibody in the lung after a primary exposure to antigen is 
produced locally by these cells (Hill et al., 1983). The few AFCs in 
control lung lobes exposed to saline also actively produce antigen- 
specific antibody (Bice et al., 1980a71989). The results of several stud- 
ies show that AFCs in the lung after a primary immunization are 
recruited into the lung and are not produced locally (Mason et al., 
1985; Bice et al., 1989). In addition, cell numbers are not amplified 
by interaction with antigen that might have been retained in the lung 
after primary immunization (Bice et al., 1982a). In addition to AFCs, 
large numbers of other lymphocytes enter the lung with a peak re- 
sponse occurring between 7 to 14 days after immunization with a mean 
of 25% of the total lavage cells being lymphocytes (Bice et al., 1989). 
Species differences exist in the release of AFCs into the blood from 
LALNs and in the recruitment of AFCs into the lung. Dogs (Bice et 
al., 1982b), nonhuman primates (Bice et al., 1982a, Mason et al., 1985), 
and humans (Stevens et al., 1979; Lue et al., 1988; Weissman et al., 
1994) all have large numbers of AFCs in their blood after immuniza- 
tion, and blood AFCs enter the lung. In contrast, data from a single 
immunization of the lungs of rats, guinea pigs, rabbits, and mice sug- 
gest that few or no AFCs are released into blood, and that relatively 
few AFCs appear subsequently in the lung (Bice and Shopp, 1988). 
However, the use of adjuvants and large doses of antigen appears to 
increase the number of AFCs in the lung of guinea pigs and mice 
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(Shopp and Bice, 1987; Curtis and Kaltreider, 1989). It is possible that 
the strain of species being evaluated may also be important, although 
no data are available that compare pulmonary B cell responses in 
different strains of laboratory animals. 
2.  Memory Responses 
Although primary immune responses are not produced in the lung 
independently of secondary lymphoid tissues, data suggest that mem- 
ory responses may be detected in the lung to antigen challenges that 
are independent of LALNs (Mason et al., 1985; Jones and Ada, 1986, 
1987; Bice et al., 1991). The most logical explanation for the production 
of AFCs and antibody in the lung after an antigen challenge is that 
immune memory cells are recruited into and/or develop in the lung 
after a primary immunization. Unlike a primary immune response, 
most specific IgG and IgA antibody produced in an immunized lung 
after a rechallenge with antigen appears to come from local immune 
memory B cells and localized production of AFCs, rather than by 
AFCs recruited into the lung from blood. Only minimal specific IgM 
is produced in the lung after antigen rechallenge (Bice et al., 1991). 
3. Long-Term Antibody Production in the Lung 
Specific antibody continues to be produced in the lung for several 
years after the last exposure to antigen (Bice et al., 1991). Lavage fluid 
from immunized and challenged lung lobes contained significantly 
more specified IgG several years after the last exposure to antigen 
than was present in lavage fluid from control lung lobes. Thus, once 
an intense, localized antibody response was established in the lung, 
immune mechanisms supported continued localized antibody produc- 
tion for several years after the last exposure to antigen, but only at the 
site of antigen exposure. 
Although AFCs were identified in lavage fluid from exposed lung 
lobes several years after antigen challenge, it was possible that cells 
in interstitial lung tissue, as well as in LALNs or distant lymphoid 
tissues, were all important in long-term antibody production. How- 
ever, the evaluation of antibody production in lung and various extra- 
pulmonary tissues showed that most long-term antibody production 
occurred in interstitial tissue in the immunized lung lobe (Bice et al., 
1993). Cells from control lung lobe tissue, from LALNs that received 
lymphatic drainage from the immunized lung lobes, from spleen, gut- 
associated lymph nodes, or popliteal lymph nodes did not produce 
significant levels of antibody 2 years after the last antigen challenge. 
Therefore, immune cells retained in lung tissue previously exposed 
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to antigens may be an important source of antibody to protect the lung. 
In addition, the absence of antibody production in LALNs or in other 
distant lymphoid tissue suggests that antibody produced in lung tissue 
exposed to antigen could possibly enter the bloodstream and provide 
immune protection for unexposed lung lobes and extrapulmonary 
tissues. 
Two possible mechanisms could be responsible for long-term anti- 
body production in lung lobes previously exposed to antigen. First, 
antigen retained in the lung, possibly on follicular dendritic cells, 
could stimulate antibody production by antigen-specific memory B 
lymphocytes that migrate through the lung. Alternatively, B lympho- 
cytes recruited into or produced in the lung in response to the initial 
antigen challenge might live for several years and continuously secrete 
antibody. Because continuous antibody production occurs only in lung 
lobes exposed to antigen, an antigen depot may be essential. Data 
have been published that support both possibilities (Tew et al., 1990; 
Peeters and Carter, 1981). 
In summary, studies suggest that pulmonary humoral immunity can 
be maintained both by continued long-term spontaneous antibody 
production and by antigen challenge restimulating local pulmonary 
memory B cells to secrete antibody. 
IV. Models for Immunity in lung Infections 
Despite the ability of the lung to express both natural and acquired 
immunity, respiratory tract infections are the most common type of 
infections experienced by humans. Certainly the common cold alone 
wins this competition hands down! Vaccination has been a powerful 
intervention to protect against many respiratory tract infections includ- 
ing the bacteria Bordetella pertussis, Corynebacteria diphtheriae, 
Hemophilus influenzae, Streptococcus pneumoniae, and M .  tuberculo- 
sis and viruses, including one virus that primarily infects the respira- 
tory tract, i.e., influenza, and several which initially infect via the 
respiratory tract, rubeola, rubella, and mumps. A major impetus for 
current research in infectious diseases is to learn more about natural 
host defenses in infections and how the immune system amplifies 
these defenses (Mason and Nelson, 1992). By better understanding 
these strategies, the hope is to optimize vaccination of immunocompe- 
tent hosts and perhaps even hosts who are immunosuppressed, yet 
retain some capacity to respond immunologically. Alternatively, in 
immunosuppressed individuals, once we are better able to understand 
how immunologically derived cytokines function in the normal host 
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during infections, recombinant forms might be administered as re- 
placement. 
The use of animal models has considerably enhanced our under- 
standing of lung infections and the role of immunity in controlling 
them. In most pneumonias caused by extracellular bacteria, recruited 
phagocytes and opsonins, especially antibody and complement, are 
required to effectively control infections, even when antibiotics are 
used. Thus, the goal for vaccination in these pneumonias is to raise 
the level of local antibody. For chronic pneumonias and pneumonias 
caused by intracellular microorganisms, the goal of vaccination is less 
clear, although protection against the viruses listed previously corre- 
lates with serum antibody levels. The best evidence supports the 
probability that enhancing CMI would be protective for immunization 
against many obligate and facultative intracellular bacteria, fungi, and 
parasites (Lipscomb, 1989; Campbell, 1993). 
In this section, examples of animal models of infectious disease that 
address how pulmonary immunity develops to various etiologic agents 
are discussed, and the type(s) of immunity that afford protection are 
indicated. While investigators have used experimental models to study 
nearly all of the infectious agents that produce respiratory infections, 
space dictates that only a few representative studies be included here. 
A. ACUTE BACTERIAL PNEUMONIAS 
1 .  Streptococcus pneumoniae 
The administration of S. pneumoniae into the lung leads to a rapid 
accumulation of neutrophils in the alveolar space. The development 
of this local inflammatory response during S. pneumoniae pulmonary 
infections was noted in early histopathological studies (Loosli, 1940; 
Wood, 1941; Loosli, 1942). Subsequent studies confirmed the require- 
ment for intact granulocyte function in the host to eradicate the pulmo- 
nary infection (Wood et al., 1946; Heidbrink et al., 1980). Studies have 
examined the mechanisms responsible for neutrophil recruitment dur- 
ing the early stages of S. pneumoniae pulmonary infection (Vial et al., 
1984; Bruyn et al., 1992). Several groups demonstrated that animals 
systemically decomplemented with cobra venom factor had an im- 
paired ability to recruit neutrophils and to clear the organisms from 
the bronchoalveolar space. A role for C5 in the recruitment of neutro- 
phils in response to intratracheally delivered S. pneumoniae was as- 
sessed by using congenic C5-sufficient (C5+) and C5-deficient (C5-) 
mice (Toews and Vial, 1984). The results indicated that C5 was im- 
portant in producing optimal, early neutrophil recruitment and bacte- 
396 MARY F. LIPSCOMB ET AL. 
rial clearance in response to S .  pneumoniae, but other chemotaxins 
must be involved, because chemotactic activity and neutrophil recruit- 
ment was found in both C5+ and C5- mice. 
Once phagocytic effector cells were recruited into the lung, neutro- 
phils and macrophages required the opsonins, immunoglobulin and 
complement, for efficient phagocytosis of the S .  pneumoniae (Guckian 
et al., 1980; Coonrood and Yoneda, 1981). The presence of C3b on 
the surface of the pneumococci is vital for phagocytosis. C3b can be 
deposited on S .  pneumoniae by either the classical complement path- 
way through interaction with antibodies or through the alternative 
complement pathway (Winkelstein, 1981; Joiner et al., 1980). Strepto- 
coccus pneumoniae that are not killed by the initial pulmonary inflam- 
matory reaction drain to LALNs and eventually enter the systemic 
circulation resulting in a bacteremic phase (Austrian, 1981). During 
this phase, type-specific antibody to capsular polysaccharide is pro- 
duced. It has been demonstrated through passive immunization stud- 
ies that the presence of type-specific antibody (IgG and IgM) in the 
serum is protective against severe pneumococcal infection (Musher 
et al., 1990). Nontype-specific antibodies to S .  pneumoniae are made 
during infection, including antibodies to cell wall components (Brown 
et al., 1983), surface protein A (Szu et al., 1983), and the F polysaccha- 
ride (Au and Eisenstein, 1981). In general, most animal studies indi- 
cate that these latter antibodies play a minimal role in providing effec- 
tive protection against infection by S .  pneumoniae (Szu et al., 1986; 
Brown et al., 1983). 
The role of secretory IgA in the prevention of pneumococcal dis- 
ease is unclear, although one mouse model demonstrated that S .  
pneumoniae-specific IgA could “arm” lung lymphocytes which subse- 
quently demonstrated antibacterial action against S .  pneumoniae (Ses- 
tini et al., 1988). IgA has been reported to fix complement and act as 
an opsonin (Hiemstra et al., 1988; Gorter et al., 1989) and thus could 
play a role preventing S. pneumoniae infection. Finally, humoral fac- 
tors other than antibody have been implicated in protection against 
S .  pneumoniae, particularly C-reactive protein which can activate com- 
plement and act as an opsonin when bound to the capsule. Although 
a role for C-reative protein has been demonstrated in clearing S. pneu- 
moniae from the bloodstream (Volanakis and Kaplan, 1971; Horowitz, 
et al., 1987), a role for C-reactive protein in the pulmonary stages of 
infections has not been demonstrated. 
2.  Haemophilus influenza 
Models for acute pulmonary infection with H .  influenza have been 
developed in the rat (Wallace et al., 1989) and mouse (Esposito and 
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Pennington, 1984; Toews et al., 1984b). The latter method delivers a 
reproducible bolus of organisms to the lower respiratory tract via an 
endobronchial catheter. Using this technique it was determined that 
the clearance of both typable and nontypable H .  influenza from lungs 
occurred at a very similar rate. The clearance of the organisms ap- 
peared to occur in two phases. During the initial 6 hr postinoculation, 
the organisms increased in numbers three- to fivefold, while during 
the next 18 hr the organisms were rapidly cleared (Toews et al., 198413). 
Studies indicated that the rapid clearance phase corresponded to the 
influx of neutrophils into the lung and that the presence of these 
leukocytes was vital for effective clearance (Toews et al., 1985). The 
effect of specific antibody to the H .  in.uenza on the rate of pulmonary 
clearance was examined using both active immunization and passive 
administration of immune sera. The results indicated that the presence 
of specific antibody in the serum and the BAL fluid of immunized 
mice correlated with an increased rate of clearance from the lung. 
That systemic IgC could provide protection in the lower respiratory 
tract of animals was also demonstrated by experiments showing en- 
hanced clearance of H. influenza from the lungs of mice that had 
received immune sera. Taken together, these results indicated that in 
the presence of elevated titers of serum IgG, protective antibodies 
could enter the airways of infected lungs to provide protection against 
pulmonary pathogens. 
3. Staphylococcus aureus 
In contrast to the organisms discussed previously, previous immuni- 
zation with S. aureus does not appear to enhance clearance or provide 
protective antibody in pulmonary infections ( Jakab, 1976). Recent 
studies suggest that the pulmonary clearance of this organism may be 
dependent on locally produced opsonins that enhance phagocytosis 
by AM. Surfactant protein A, produced by type I1 pneumocytes, can 
bind to S. aureus and increase phagocytosis, while this protein does 
not enhance uptake of S. pneumoniae by AM (McNeely and Coonrood, 
1993). 
B. CHRONIC BACTERIAL AND FUNGAL PNEUMONIAS 
Lung infections with two microorganisms, Mtb and Cryptococcus 
neoformans (Cne), are discussed in this section as examples of infec- 
tions requiring intact CMI for resolution. Animal models of chronic 
lung infections with several other important pathogenic organisms 
have been studied, including Pneumocystis carinii (Walzer, 1984; Shel- 
lit0 et al., 1990; Harmsen and Stankiewicz, 1990; Boylan and Current, 
1992), Histoplasma capsdatum (Baughman et al., 1986; Defaveri and 
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Graybill, 1991; Fojtasek et al., 1993; Allendoerfer et al., 1993), Blasto- 
myces dermitiditis (Morozumi et al., 1982; Moser et al., 1988; Frey 
et al., 1989; Williams et al., 1994), Paracoccidiodes braziliensis (Brum- 
mer et al., 1984; Defaveri et al., 1989), Coccidiodes immitis (Cox et 
al., 1988), Chlamydia trachomatis and psittaci (Williams et al., 1988), 
Rhodococcus equi (Kanaly et al., 1993), and Mycobacterium auium- 
intracellulare (Takashima and Collins, 1988). Although infection with 
Legionella pneumophila can cause an acute pneumonia in susceptible 
hosts, it is a facultative intracellular bacterium; CMI is thought to be 
necessary for resolution of the infection. An animal model to study 
this infection has also been developed (Skerrett and Martin, 1991). 
A central role for CMI (in which T cells recruit and activate macro- 
phages) in controlling intracellular bacterial infections was first pro- 
posed by George Mackaness using a Listeria monocytogenes murine 
infection model (Mackaness, 1964). After finding an important role for 
CMI in controlling an aerogenous Listeria infection in mice, Macka- 
new extended his studies to propose that cell-mediated hypersensitiv- 
ity might be an important cause of lung disease (Mackaness, 1971). 
However, he and his collaborators observed that, in contrast to protec- 
tion afforded by active immunization, adoptive transfer of Listeria 
immune splenocytes seemed to afford only minor protection against 
an aerosolized infection (Truitt and Mackaness, 1971). In retrospect, 
adoptive immunity might have been transferred more successfully if 
LALNs or lung lymphocytes from aerosol-infected mice had been used 
instead of spleen cells from systemically immunized mice; these latter 
cells likely homed inefficiently to the infected lung (Huffnagle et 
al., 1991b). Nevertheless, in experiments with virulent Mtb, when 
organisms were given iv, the lung developed effective resistance, al- 
though less effectively than spleens and livers (Mackaness, 1971). 
These early studies suggested that CMI in the lung might be more 
rigidly downregulated, perhaps to prevent excessive damage to deli- 
cate structures. However, Mackaness offered an additional explana- 
tion, e.g., lung infections with Mtb may be more difficult to control 
locally because organisms are sequestered in AM, macrophages that, 
in contrast to recruited monocytes, might resist activation signals deliv- 
ered by T cells. 
1 .  Mycobacterium tuberculosis 
The role of pulmonary immunity during Mtb infection has been 
analyzed in a variety of animal models (Smith and Wiegehaus, 1989) 
including rabbits (Lurie, 1964), mice (Orme and Collins, 1984; North 
and Izzo, 1993), and guinea pigs (Smith and Harding, 1977). Initial 
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experiments involved intranasal or intratracheal inoculation and the 
development of the Middlebrook chamber (Middlebrook, 1952) pro- 
vided a means of aerosolizing Mtb into animals. Early studies exam- 
ined the number of Mtb required for a reproducible infection in ani- 
mals. Mice exposed to a mist of virulent Mtb developed discreet 
lesions that were progressively fatal over a 10-21 week period 
(Schwabacher and Wilson, 1937). These initial studies were extended 
by comparing aerosol versus intranasal delivery of Mtb and it was 
found that both routes produced similar pathology. It was observed 
that a deposited inoculum of about 100 organisms was required for 
reproducible infection, while a dose of approximately 12,000 organ- 
isms resulted in death (Glover, 1944). 
Resident AM undoubtedly play a role during an Mtb infection. Mtb 
deposited into the lung are rapidly taken up by AM. Evidence for a 
role for AM in defense against Mtb partly comes from epidemiologic 
studies examining Mtb infections in individuals with silicosis (Snyder, 
1978). Silica exposure results in the uptake of silica particles by AM. 
These silica particles remain in the phagolysosomes of AM throughout 
the life of the individual (Allison and D’Accy Hart, 1968) and likely 
affect their function. Essentially all epidemiological studies examining 
the incidence of Mtb infections in a silica-exposed population have 
concluded that the incidence of Mtb infections in this group is signifi- 
cantly higher than the incidence of Mtb infection in a non-silica- 
exposed population (Snyder, 1978). 
Several studies have shown that both human and/or mouse AM are 
stimulated to produce chemotactic factors and cytokines in response 
to Mtb or components of the Mtb cell wall (Barnes et al., 1992; Chat- 
terjee et al., 1992). These released products may represent an early 
native defense system against Mtb. Thus, chemotactic factors can act 
to recruit neutrophils and monocytes from the circulation, while AM- 
released cytokines, such as TNFa, can activate both local AM and 
newly recruited cells. Indeed, some studies indicate that cytokine- 
activated AM and/or monocytes can inhibit the growth of or kill Mtb 
(Crowle, 1990; Rastogi, 1990; Denis, 1991a). More recent data suggest 
that macrophage cytokines, including IL12, may enhance the develop- 
ment of the Th l  subset leading to protective immunity (Hsieh et al., 
1993). Data indicating that avirulent Mtb can elicit a greater cytokine 
response from macrophages than virulent Mtb have lead to the hypothe- 
sis that the observed differences in Mtb virulence may be due to an 
intrinsic ability of virulent Mtb to prevent or decrease the release of 
factors by AM (Barnes et al., 1992; Chatterjee et al., 1992; Roach et al., 
1993). Ethnic differences observed in susceptibility to Mtb (Coultas et 
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al., 1993) might be due to a genetic disposition for a poor initial re- 
sponse by AM to Mtb. 
A role for CMI was demonstrated for protection against Mtb infection 
(Suter, 1961; Leveton et al., 1989). In a guinea pig model, it was 
demonstrated that in animals given a low dose of Mtb, the organisms 
replicated in a log phase until Days 19 or 20, after which exponential 
growth ceased (Smith and Harding, 1977). The decrease in growth 
coincided with the onset of tuberculin skin test sensitivity and the 
development of detectable bacillemia. Bacteriostasis ensued over the 
next 40-50 days after which the numbers of Mtb in lung were gradually 
reduced. Although these data were consistent with a role for the devel- 
opment of an acquired CMI response for resolution of the Mtb infec- 
tion, it was not until Orme and Collins (1984), by examining the im- 
mune response in a mouse model, that direct evidence was provided 
for a role of T cells in pulmonary immunity against Mtb. In a series 
of adoptive transfer experiments, they removed splenic T cells from 
a mouse that had received an iv inoculation of Mycobactel-ium bovis or 
BCG. After injecting these BCG-immune T cells into thymectomized, 
sublethally irradiated nonimmune mice, the mice were challenged 
with an aerosol dose of Mtb that deposited lo4 organisms into the 
lungs. Two important findings in these studies were (1) adoptively 
transferred immune T cells enhanced clearance of Mtb from the lung; 
and (2) by differentially removing subsets of T cells with specific 
antisera, the skin test tuberculin sensitivity was dissociated from protec- 
tive antituberculous immunity which indicated that separate popula- 
tions of T cells may be responsible for the two events. In a follow- 
up study (Orme, 1987), only Mtb-immune CD8 T cells adoptively 
transferred protection to mice challenged with a lethal aerosol inocu- 
lum (1.5 X lo5 organisms) of Mtb, while either CD4 or CD8 cells could 
transfer protection to mice exposed to a low dose (500 organisms) 
of Mtb. 
In comparison to the pulmonary inoculation studies, models using 
intraperitoneal or iv routes of inoculation have produced different 
results. In an intraperitoneal model, an Mtb-reactive CD4 T cell clone 
provided both a DTH response and protection as measured by the 
growth of Mtb in the peritoneum (Pedrazzini and Louis, 1986). Simi- 
larly, an Mtb-immune CD4 T cell clone provided protection, as mea- 
sured by reduced splenic CFU, following an iv Mtb infection. Another 
study using in vivo depletion of T cell subsets demonstrated that 
depletion of CD4 T cells decreased resistance to iv infection, while 
depletion of CD8 T cells did not have a significant effect (Pedrazzini 
et al., 1987). In contrast, in a similar model, transgenic mice incapable 
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of producing CD8 T cells were shown to have a decreased resistance 
to Mtb compared to normal mice (Flynn et al., 1992). 
A role for y6 T cells in pulmonary defenses against Mtb is unresolved 
(O’Brien et al., 1989; Kaufmann and Kabelitz, 1991). Because y6 T cells 
release IFNy, it is tempting to speculate that these T cells represent an 
initial defense mechanism in the lung to provide activating cytokines 
to enhance local effector mechanisms to help control the infection 
until the development of protective immunity by ap T cells. Initial 
studies demonstrated an increase in the number of lung y6 T cells 
after an intratracheal dose of PPD (Janis et al., 1989). Other studies 
suggested that many y6 T cells responded to the heat-shock protein 
of Mtb (Born et al., 1991; Kaufmann and Kabelitz, 1991). Other studies 
suggested they may play a role in granuloma formation (Modlin et al., 
1989). However, in humans with active Mtb infections, there was no 
increase in y6 T cells in the granuloma as determined by immunohisto- 
chemical staining (Tazi et al., 1991). More work in animal models and 
human natural infections is required to define the role of y6 T cells in 
mucosal immunity, particularly regarding their role in Mtb infections. 
Complex interactions exist in the development of protective immu- 
nity by T cells and the type of cytokines produced during an infection. 
Similar to the studies that show an important protective role for Th l  
cells that preferentially secrete IFNy in Leishmania infections (Lock- 
sley et al., 1991), it is likely that mechanisms for production of appro- 
priate cytokines are critical in the development of protective immunity 
against Mtb (Flesch, 1990; Denis, 1991b; Kawamura et al., 1992; 
Barnes et al., 1993; Orme et al., 1993) as well as in the maintenance 
of a resistant state during the chronic infection stage. An important 
role for IFNy in Mtb resistance was recently demonstrated in both an 
aerosol and an iv Mtb infection model. Comparing infected normal 
and IFNy knockout mice (Cooper et al., 1993; Flynn et al., 1993), it 
was demonstrated that a lack of IFNy resulted in a significant increase 
in Mtb susceptibility. However, since IFNy was absent throughout 
the course of infection, it was unclear at what stage in the immune 
response IFNy was required (Flynn et al., 1993). Indeed, IFNy may 
be important for all aspects of the response to Mtb including T cell 
development, cell recruitment, and activation of effector mechanisms. 
Other studies in mice examined the granulomatous response to iv- 
injected BCG in animals that had received neutralizing antibody to 
TNFa (Kindler et al., 1989). These and other studies (Amiri et al., 
1992) indicate that TNFa also plays a critical role in protection against 
M tb, particularly in the development and maintenance of granulomas. 
Attempts to vaccinate animals with avirulent or killed Mtb have 
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provided important data regarding potential vaccines. In general, stud- 
ies suggest that to enhance the immune response against virulent Mtb, 
viable organisms must be used (Larson and Wicht, 1962). The route 
of immunization with viable organisms can be either iv or by aerosol. 
Further, vaccination does not prevent infection, but rather limits tissue 
destruction and the degree of hematogenous dissemination (Harding 
and Smith, 1977). Immunization with nonviable cellular elements does 
not afford protection. 
In summary, the development of protective immunity to a pulmo- 
nary infection with Mtb requires the coordinated activity of multiple 
cell types, particularly macrophages and T cells. The continued study 
ofthe Mtb pulmonary infection should aid in understanding the mecha- 
nisms for developing effective CMI in the lung and suggest strategies 
to enhance pulmonary defenses. 
2. Cryptococcus neoformans 
Cne is an encapsulated yeast found in desiccated form in soil, particu- 
larly in areas contaminated by pigeon feces. Cne usually causes only 
an asymptomatic infection in humans following inhalation. Normal 
individuals typically clear the organisms, but in those who are suscepti- 
ble, particularly those with defects in CMI, the organism may dissemi- 
nate via the bloodstream and produce an extrapulmonary infection, 
usually meningitis. Mice have been used as experimental models for 
studying the host defenses against this microorganism, which because 
of the capsule resists endocytosis and thus typically replicates in tis- 
sues in an extracellular location. In murine models the organism was 
frequently inoculated iv or ip, although it had been established many 
years ago that mice housed on contaminated bedding (Smith et al., 
1964), exposed to aerosols (Karaoui et al., 1977), or that received intrana- 
sal inoculations of the organism (Ritter and Larsh, 1963) developed 
infection. These early studies validated the concept that the organism 
was acquired by the respiratory tract. Murphy and her colleagues have 
contributed substantially to the understanding of immune and natural 
defense mechanisms in protection against this yeast and demonstrated 
that animals inoculated intranasally developed pulmonary infection 
that disseminated, but following the development of DTH gradually 
cleared the infection (Lim et al., 1980a). Furthermore, these investiga- 
tors demonstrated that transfer of T cell-enriched splenocytes from 
mice immunized by an intranasal infection was capable of protecting 
mice against an iv challenge (Lim et al., 1980b). Of importance was 
that in these studies, passive transfer of serum failed to protect mice. 
We and others developed an intratracheal inoculation infection 
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model with Cne to study pulmonary immune mechanisms in mice (Hill 
and Harmsen, 1991; Huffnagle et al., 1991a; Huffnagle and Lipscomb, 
1992). In our model, the organism is inoculated in small amounts 
directly into the trachea and yeasts in the lungs are quantitated by 
homogenizing the organ and measuring colony-forming units (CFU). 
Over an initial 7 days, the organisms grow rapidly followed by a gradual 
decrease in CFU in appropriate mouse strains, a process referred to 
as “lung clearance” (Huffnagle and Lipscomb, 1992). An important 
aspect of this model, as is true of many other lung infection models, is 
that both the strain ofmicroorganism and the strain of mouse determine 
whether the infection will be cleared from the lung and at what rate 
(Huffnagle et al., 1991a). In studies using a relatively low virulence 
encapsulated yeast, athymic nude mice, mice with severe combined 
immunodeficiency (SCID), or mice depleted of CD4 and CD8 T cells 
were incapable of pulmonary clearance (Huffnagle et al., 1991a,b; 
Huffnagle and Lipscomb, 1992; Hill and Harmsen, 1991). Further- 
more, protection of the lung was adoptively transferred to SCID mice 
by splenic lymphocytes, but adoptive immunity was more effective if 
lymphocytes isolated from the lungs and LALNs of animals that had 
been immunized during a lung infection were used (Huffnagle et al., 
1991b). Interestingly, using a more virulent organism, CD4 T cells 
were responsible for increased resistance to the highly virulent organ- 
ism following extrapulmonary spread, but did not demonstrate an ef- 
fect in controlling the infection within the lung (Mody et al., 1990). 
These latter studies demonstrated, as did the earlier studies of Macka- 
ness, a dichotomy between the ability of immunized animals to demon- 
strate effective immunity in the lung compared to extrapulmonary 
organs. 
What is the role of CD4 and CD8 T cells in immune protection? 
The absence of either reduced the numbers of inflammatory cells, 
including macrophages, but they were even more profoundly de- 
creased when both were absent (Huffnagle et al., 1994). A role for 
CD8 T cells was repeatedly shown in strains of mice that demonstrated 
acquired resistance to low-virulence Cne, i.e., BALB/c, C.B-17 (con- 
genic to BALB/c, but with the IgH locus of C57BL/6 mice), and CBA 
mice (Hill and Harmsen, 1991; Huffnagle et al., 1991a; Mody et al., 
1993). A role for CD8 T cells in this infection was particularly curious, 
although CD8 cells clearly participate in the development of immunity 
to intracellular organisms. Mechanisms proposed include secretion of 
IFNy or lysis of infected targets following recognition by CD8 T cells 
of peptides in the context of class I MHC (Kaufmann, 1988). However, 
it is not known how CD8 cells function in murine Cne disease in which 
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the organism is primarily extracellular. One important mechanism may 
be related to their capacity to enhance either the clonal expansion or 
the recruitment of CD4 cells to the lung (Huffnagle et al., 1994). Thus, 
CD8 T cell depletion of Cne-infected mice reduced the numbers of 
CD4 T cells in infected lungs. A second role may relate to the finding 
that lung cells isolated from CD4 T cell-depleted animals were capable 
of secreting IFNy in mitogen-stimulated cultures, suggesting CD8 
cells in this setting could also contribute to IFNy production and play 
a role in macrophage activation. It was also demonstrated that CD8 
cells played a critical role in the development of DTH to Cne in Cne- 
infected mice and could adoptively transfer DTH (Mody et al., 1994). 
This is an important observation because it proves CD8 T cells can 
recognize antigens of extracellular organisms in the context of class I 
MHC. Thus, it is possible that CD8 T cells might lyse AM that phagocy- 
tose the organism, but cannot kill it, so that activated macrophages or 
other effector cells may play a role. 
C.B-17 mice were particularly adept in the development of a Thl  
response characterized by clearing Cne from their lungs, and this 
ability was related to enhanced secretion of IL-2 and IFNy by LALN 
cells early in infection (Hoag et al., 1994). The heightened resistance 
in C.B-17 mice correlated with expression of the inducible nitric oxide 
synthase (iNOS) gene in the lungs, was accompanied by secretion of 
NO by lung cells during the early clearance phase, and was completely 
abrogated by both anti-IFNy treatment and feeding animals an inhibi- 
tor of NO production (Lovchik et al., 1995). Thus, in C.B-17 mice, 
clearance in the lung was related to the capacity of the animals to 
make IFNy and NO. 
If T cells are necessary to protect lungs from Cne infections, is the 
effector mechanism mediated mainly by activation of macrophages? 
The answer to this question is still uncertain, but rat AM activated by 
IFNy were able to inhibit the growth of Cne (Mody et al., 1991). 
Furthermore, prolonged incubation with GM-CSF also activated AM 
for Cne growth inhibition (Chen et al., 1994). Murine macrophages 
from the peritoneum of BCG-immunized mice inhibited the growth 
of Cne in vitro by an arginine-dependent mechanism and were related 
to NO production (Granger et  al., 1988; Alspaugh and Granger, 1991) 
consistent with the in vivo data of Lovchik (1995). An important aspect 
of growth inhibition by this NO-dependent mechanism was that it did 
not require endocytosis, although endocytosis enhanced the growth 
inhibition (Granger et al., 1986). Others have demonstrated that IFNy- 
activated mouse macrophages kill Cne, but determined that a secreted 
protein was important (Flesch et  al., 1989). Activated human macro- 
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phages make little if any NO unlike rat and mouse macrophages leav- 
ing open the question of what effector mechanism human macrophage 
may use to growth inhibit Cne. 
Human neutrophils and macrophages not only inhibited growth, but 
killed, Cne in cultures that include fresh complement (Miller and 
Mitchell, 1991). The organism fixes complement by the alternate path- 
way resulting in C3bi binding to the yeast capsule and allowing phago- 
cytosis by CR3-positive neutrophils and macrophages (Kozel and 
Pfrommer 1986; Kozel et al., 1988). This mechanism was shown to 
play an important role in clearing Cne from the pulmonary vasculature 
during fungemic states in mice (Lovchik and Lipscomb, 1993). How- 
ever, Cne in tissues tend not to provoke brisk inflammation, and bron- 
choalveolar spaces (and cerebrospinal fluid) do not contain significant 
complement. Furthermore, AM may not express CR3. Thus, T cells 
must amplify effector systems by recruiting and/or activating nonspe- 
cific effectors or by themselves becoming direct effectors. 
Recent studies indicated that human NK cells and T cells had direct 
activity in vitro against Cne (Levitz et al., 1994; Murphy et al., 1993), 
although there was conflicting evidence that human NK cells had no 
growth-inhibiting activity unless antibody against the organism was 
present (Miller et al., 1990). We demonstrated that murine NK cells 
had a minor effect against the organism following iv inoculation, 
but failed to play a role in early lung clearance if the organism was 
inoculated via the trachea (Lipscomb et al., 1987). Recently a T cell- 
independent, partially protective host defense mechanism was found 
in lung clearance in SCID mice and BALB/c mice depleted of CD4 
andCD8Tcells. AThyl+,CD4-,CD8-,asialoGMl-cell was responsi- 
ble (Hill and Dunn, 1993). Further studies are clearly indicated to 
examine the role of this cell in animal models and to identify its origin, 
particularly in view of the possible importance of these cells in human 
Cne infections. 
Histologic examination of murine lungs during the clearance phase 
demonstrated that yeasts were surrounded by macrophages with an 
activated appearance (Hill, 1992; Huffnagle and Lipscomb, 1992). This 
appearance was similar to that seen in the lungs of humans with crypto- 
coccomas who are known to be able to resolve their infections without 
antibiotic therapy. When the lung becomes inflamed and complement 
is available, neutrophils may play some role in killing Cne in the 
lung, although the relative importance of neutrophils over T cells and 
activated macrophages remains to be clarified. 
Continued studies using a murine Cne lung infection model should 
help elucidate the mechanisms that lead to the development of a 
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Thl-like response in LALNs early during infection and subsequent 
recruitment of lymphocytes and macrophages into the lung. A closer 
examination of what effector mechanisms are at work in the lungs of 
animals that clear a Cne infection, particularly in resistant mouse 
strains that may not utilize NO from activated macrophages, may help 
elucidate host defense mechanisms in man. 
C. VIRAL PNEUMONIAS 
Viruses are intracellular organisms that usurp host cellular machin- 
ery to replicate. Viral entry into cells can be blocked by antibodies. 
However, once inside the cell, the virus is resistant to both antibody 
and T cell recognition until viral peptides are presented in the context 
of class I MHC antigens on the cell surface and allow specific cytotoxic 
T cells to lyse the infected cell (Zinkernagel, 1993). As viral replication 
ensues and particles are released from the cell surface, antibody again 
has an opportunity to block the further spread of the virus. In general, 
cytotoxic T cells play an important role in controlling local viral replica- 
tion, while antibody can prevent initial infection and extracellular 
spread within the host. In some viral infections, there seems to be a 
relatively minor role for CD4 T cells (Zinkernagel, 1993). However, 
in a number of viral infections in mice, depletion of CD4 T cells 
increased mortality and reduced the rate of clearance. The role for 
CD4 cells may relate to providing help for cytolytic T lymphocyte 
(CTL) development (Reiss and Burakoff, 1981) and for B cell produc- 
tion of high-affinity IgG and IgA antibodies. The role of y6 T cells, 
NK cells, and macrophages in acute viral infections is still not clear. 
Furthermore, whether memory CTLs play an important role in pre- 
venting recurrent infection is also uncertain (Zinkernagel, 1993). It is 
also uncertain whether persistence of long-term memory T or B cells 
against viruses requires the continued presence of virus or viral parti- 
cles (Zinkernagel, 1993; Sprent, 1994). 
A large number of viruses infect the respiratory tract, including 
rhinoviruses, coronaviruses, adenoviruses, influenza, and parainflu- 
enza viruses, respiratory syncytial virus (RSV), measles, mumps, and 
rubella viruses. Good models in mice exist for both RSV and influenza 
A infections and are discussed to highlight experimental models that 
have provided insight into immune defenses against viral respiratory 
tract infections. 
1 .  Respiratory Syncytial Virus 
Immunization against influenza A with killed or fractionated viral 
antigens protects against influenza, but immunization against RSV has 
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been problematic (Salk and Salk, 1977; Wright et al., 1982; Graham et 
al., 1993; Alwan et al., 1994). Protection against RSV, which produces a 
bronchiolitis in infants and is the most common cause for hospitalizing 
infants in Western countries, was not afforded by immunization with 
formalin-inactivated virus. Subsequent infection after such immuniza- 
tion sometimes resulted in unusually severe infections and even death 
(Kapikian et al., 1969; Kim et al., 1969). The mechanism is unknown, 
but various theories include immune complex disease, a CD4 T cell- 
mediated DTH reaction, or a CTL-mediated pneumonitis (Graham et 
al., 1993). Recent efforts using RSV infections in mice have sought to 
understand what the mechanisms for protection might be, and why 
immunization might lead to enhanced pathogenicity with a subsequent 
challenge. 
Depleting mice of either CD4 or CD8 cells reduced the disease in 
the lung following an initial RSV infection, but also enhanced virus 
replication (Graham et al., 1991). Thus, control of viral replication 
during even a primary infection resulted in lung pathology. At least 
two groups attempted to determine whether various viral subunits 
might initiate protective immunity, yet cause minimal pathology. Mice 
vaccinated either parenterally or by intranasal inoculation, followed 
by nasal RSV challenge, lead to the expression of cytokine mRNA in 
the lungs (Graham et al., 1993). The specific cytokine mRNA detected 
was dependent on whether live, heat-killed, or subunit vaccines were 
given. Inactivated virus or subunit fusion (F) protein induced cytokine 
expression that suggested a Th2-like lymphocyte response with in- 
creased IL-4 mRNA relative to IFNy expression. In contrast, when 
mice were primed with parenteral or nasal live virus, Thl  responses 
were prominent. Formalin-fixed virus and the F protein component 
were somewhat protective. However, the most effective protection 
was induced by immunizing intranasally with the live virus. Further- 
more, this immunization protocol resulted in the least lung pathology 
after rechallenge. 
Experiments were designed to determine which T cell types caused 
pathology and whether specific RSV subunits evoked specific 
pathology-producing immune T cells. Cell lines were developed from 
immune lymphocytes of mice immunized against the F protein, the 
major surface glycoprotein (G), and a 22-kDa matrix protein expressed 
by recombinant vaccinia virus (Alwan et al., 1994). F protein lead to 
the development of both CTL and CD4 T cells with a Th l  phenotype. 
G protein facilitated the development of CD4 cells with a Th2 pheno- 
type. Immune cells from the 22-kDa protein-immunized mice resulted 
in predominantly CD8 CTL. Representative cell lines from each of 
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these groups transferred both protection and pathogenic effects to 
RSV-infected mice, but the Th2 cells seemed to be the most damaging. 
Furthermore, combinations of lines afforded the greatest protection. 
Thus, protection is often synonymous with pathology and it may be 
difficult to dissoeiate the two. 
l, 2.  Influenza Virus 
It has been clear for some time that serum antibody correlates with 
protection against influenza viruses. Influenza viruses exhibit anti- 
genic drift and shift that requires individuals be immunized yearly 
for protection against the prevalent virus strain (Zinkernagel, 1993; 
Salk and Salk, 1977). While immunization against influenza has been 
successful, it is possible that new immunization protocols might be 
developed that would be broadly protective. In contrast to B cell 
epitopes, T cell epitopes may be cross-reactive; cytotoxic T cells seem 
to play an important role in controlling influenza infections (Zinkerna- 
gel and Althage, 1977). 
Early studies established that recovery of mice from infections with 
influenza A required the development of a CTL response to the virus, 
and protection was afforded by the adoptive transfer of immune cells 
into naive-infected hosts (Yap et al., 1978; Lukacher et al., 1984). 
Further studies indicated that both class I and I1 MHC-restricted T 
cell clones could promote recovery from a lethal pulmonary infection 
(McDermott et al., 1987). These T cell clones were preferentially 
retained in lungs of influenza-infected mice, independent of any viral 
antigenic specificity, and migrated from the pulmonary vessels into 
the bronchiolar lumens. Thus, the immune cells accumulated at a site 
appropriate to provide protection against a viral challenge. 
Mice die within 6 days of lethal influenza infections. An array of 
cytokines could be detected in BAL fluids in these mice, but none 
that were unequivocally indicative of a T cell response (Hennet et al., 
1992). Thus, while IL-la, IL-lP, IL-6, TNFP, GM-CSF, IFNy, and 
leukotriene B4 were identified in lavages, IL-2, IL-3, and IL-4 were 
not. On the other hand, in sublethal infections in which the influenza 
infection was resolved, examination of cells from lavages as well as 
from LALNs demonstrated T cell cytokine production (Carding et al., 
1993; Sarawar et al., 1993). In a primary infection, the kinetics of 
cytokine mRNA was compatible with an initial response occurring in 
the regional lymph nodes with the effector T cells appearing later in 
the lungs. Among the aP T cells, transcripts for IFNy and TNFP were 
predominantly found in CD8 cells, but there was a tendency for IL- 
4 and IL-10 to appear in CD4 cells. Interestingly, y8 T cells were 
identified and expressed IL-2, IL-4, and IFNy. During a secondary 
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response, T cell cytokine mRNA was found almost simultaneously in 
LALNs and in the lung (Carding et al., 1993). In related studies, mRNA 
was detected by in situ hybridization and by cytokine production 
identified in individual cells by ELISPOT. The majority of cells in 
lavages produced IL-2, IL-4, and IFNy with relatively little TNF and 
IL-10. Depletion of CD4 and CD8 cells caused a significant reduction 
in IL-2- and IL-4-producing cells, but IFNy-producing cells remained 
and were likely CD4-, CD8- ap, or y6 T cells; both populations were 
present during the infection. 
These studies are typical of recent studies examining cytokine pat- 
terns in various lung infections in the lung attempting to learn what 
determines the type of immune response that develops to airway anti- 
gens. B2-Microglobulin-deficient mice were used to determine the 
effect of IFNy on influenza clearance. Mice did not develop CD8 CTL 
because of the absense of class I MHC, but residual CD4 cells were 
capable of mediating clearance, possibly related to the development 
of antibody of the IgG2a subclass (Sarawar et al., 1994). Treatment of 
the mice with anti-IFNy antibody delayed clearance for at least 3 days, 
whereas antibody to IL-4 had no effect. However, all mice survived 
and eventually cleared the virus. Notably, neither antibody to IFNy 
nor IL-4 altered the cytokine profiles detected in freshly isolated lung 
lymphocytes. The conclusion was that although IFNy played an im- 
portant role in viral clearance, its role was not to drive CD4 cells to 
become Th l  T cells. 
y6 T cells developed as a prominent component of the late inflamma- 
tory process during murine influenza infections (Carding et al., 1990). 
These cells expressed all known y genes, although some predominated 
at times. A suggested role for these cells was that they recognized 
heat shock proteins on inflammatory macrophages and decreased their 
numbers. However, close examination of the data failed to show an 
inverse relationship of the numbers ofy6 T cells and lung macrophages 
(Carding et al., 1990). In another study, y6 T cells were found to be 
noncytolytic, but expressed mRNA for IFNy, GM-CSF, and TNFP 
(Eichelberger et al., 1991). The hypothesis was presented that these 
cells, through their capacity to make cytokines, provided nonspecific 
protection against secondary infections. Thus, although 76 T cells are 
a component of the host response to viral lung infections, their role 
remains unknown. 
D. IMPLICATIONS FOR VACCINATION 
A National Institutes of Allergy and Infectious Diseases (NIAID) 
Blue Ribbon Panel on Vaccine Research was convened in 1993 by 
Anthony Fauci, Director of the NIAID, to assess the long-term goals 
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for vaccine research and to recommend immediate priorities for the 
institute. Among the panel’s recommended priorities was the develop- 
ment of vaccines for respiratory infections of children, and to improve 
the current vaccines for pertussis and measles. An additional priority 
was to develop vaccines for reemerging infectious diseases, including 
influenza because of its inherent problems of antigenic drift and 
shift. 
The Jordan Report, a publication of the Division of Microbiology 
and Infectious Diseases of the NIAID, has reviewed on a yearly basis 
the progress in vaccine research. In the 1993 report, respiratory tract 
infectious diseases for which vaccines were either being developed 
or improved were listed and discussed. They included the bacteria 
Groups A and B Streptococci, H. influenzae type B, nontypable H. 
influenzae, Neisseria meningitidis, S .  pneumoniae, B .  pertussis, Pseu- 
domonas aeruginosa, and M .  tuberculosis; the viruses Rubeola, ru- 
bella, adenoviruses, influenza, and parainfluenza viruses, and respira- 
tory syncytial virus; Mycoplasma pneumoniae; and the fungi, H. 
capsulatum, C. immitis, and C .  neoformans. Thus, an enormous scien- 
tific effort is being directed at designing vaccines to protect the host 
from respiratory pathogens. And yet the report also highlighted the 
gaps in our knowledge about normal host defenses at mucosal surfaces, 
what immune defenses we should attempt to enhance with vaccina- 
tions, and the best methods for immunization. 
Important issues for vaccine research have been discussed in recent 
publications (Lambert, 1993) including reviews on the possibilities of 
immunization against tuberculosis (Kaufmann and Young, 1992) and 
on novel approaches to vaccination such as inoculating polynucleo- 
tides encoding antigens directly into muscle (Donnelly et al., 1994). 
Important general goals for any vaccine are that it be efficacious, 
easy to store, easy to give, and be free of side effects. Specific goals 
for vaccines for respiratory infections are (1) the immune response 
generated must be protective (a corollary is that the immune response 
to a microbial challenge should not cause lung pathology.); (2) the 
immune response must be quickly available in the respiratory tract 
and at the site within the respiratory tract where the microorganism 
is likely to seek entrance and/or produce disease; and (3) immune 
memory should be long term. 
The study of the type of protective immune responses that develop 
during natural infections in man or induced infections in experimental 
animals has provided important clues to what responses should be 
enhanced by immunization. This has been a productive approach for 
viral infections and those caused by intracellular pathogens. However, 
host responses that can prevent a second infection may differ from the 
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immune responses that bring an acute infection under control. For 
example, in many viral infections, although cytotoxic T cells may bring 
a primary infection under control, antibody may prevent reinfection. 
Another example of this principle is that although CMI controls Cne 
infections in mice, in special circumstances, antibodies to Cne can be 
protective (Mukheqjee et al., 1992). The isotype of the predominating 
antibody in preventing infection may also be extremely important, 
e.g., upper tract infections may be more dependent on IgA responses, 
while in the alveolar spaces, IgG may be more effective. 
As already discussed, an important consideration for viral vaccines 
is whether subunit vaccines are as effective as live attenuated organ- 
isms in initiating the desired type of immune response. An innovative 
strategy for generating CMI responses against nonviable antigens is 
to inoculate a regulatory cytokine at the time of antigen delivery 
(Afonso et al., 1994). The vaccine could even consist of a fusion protein 
of the antigen and the cytokine (Tao and Levy, 1993). 
The immune response at the time of challenge must develop in the 
correct site. If the organism infects the upper respiratory tract, local 
IgA is important. If infection is initiated in the lower respiratory tract, 
it may be sufficient that protective cells and antibody are available in 
circulation if recruitment can occur immediately following challenge. 
However, if significant inflammation is required before recruitment 
of immune cells occurs, some clinical manifestations of infection must 
necessarily develop, before the protective response neutralizes the 
infection. Feasible strategies for generating IgA in the upper respira- 
tory tract are to aerosolize the antigen, to deliver the relevant antigens 
on the surface of a nonpathogenic microorganism, such as Streptococ- 
cus gordonii, that have the potential to colonize the nasopharynx (Pozzi 
et al., 1992), or to immunize with oral vaccines with antigens either 
chemically bound to cholera toxin B-subunit (McGhee et al., 1992), 
enclosed in a liposome or biodegradable microsphere (Mestecky and 
Eldrigde, 1991), or encoded in a plasmid carried by live attenuated 
Salmonella spp. (Ckdenas and Clements, 1992). Ample evidence has 
documented that IgA precursors generated in the gut home to bron- 
chial mucosa (Weisz-Carrington et al., 1987; Chen et al., 1987; Rued1 
et al., 1994), although the converse does not appear to occur to an 
appreciable extent (McDermott and Bienenstock, 1979; Joel and Cha- 
nana, 1987; VanCott et d. ,  1994). However, a cautionary note in rela- 
tionship to immunizations that enhance IgA responses is that they 
could also stimulate IgE responses and lead to allergic responses in 
the lungs. Oral immunization with protein antigen and cholera toxin 
resulted in anaphylaxis in mice following an intraperitoneal antigen 
challenge (Snider et al., 1994). 
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An important issue for any vaccine is whether long-term memory is 
possible. Based on the data derived from immunization with subunit 
vaccines or killed microorganisms, it seems unlikely that sufficient T 
cell memory could be induced for long-term CMI protection against 
respiratory tract infections. However, in the presence of continuous 
antigen, such as would occur with low levels of replicating attenuated 
viruses or retained intracellular microorganisms in Ia-positive APC, 
memory T cells should persist. Furthermore, follicular dendritic cells 
are present in BALT, and long-term B cell memory could also persist 
due to the retention of nonviable antigens in the form of antigen-anti- 
body complexes on these cells. Evidence that long-term B cell memory 
occurs in the lungs of dogs has been obtained as discussed previously. 
However, it is important to remember that this observation was made 
in animals in which the antigen was directly instilled into the lung. 
Therefore, it is not obvious that extrapulmonary immunization would 
induce retention of long-term local B cell memory, and suggests that 
lung immunity might be more effective if primary immune responses 
to pulmonary pathogens were boosted by intranasal or aerosol antigen 
delivery. 
V. Models for Hypersensitivity Lung Disease 
Animal models of human lung disease have been used to test hypoth- 
eses under well controlled conditions and to dissect mechanisms of 
injury, inflammation, and repair. These models have been particularly 
useful in distinguishing direct lung toxicity from injuries that result 
from immune mechanisms. 
To prove that a lung injury is immune mediated requires previous 
exposure to an appropriate agent, evidence of a specific immune re- 
sponse, and evidence that the injury involves recognized immunologic 
mechanisms. Early work concentrated on dissecting isolated aspects 
of the immune response, i.e., the role of antibody, antibody plus com- 
plement, or T cells, emphasizing in vivo analogs of in vitro events. 
Current models of immune-mediated injury emphasize the interrela- 
tionships among these aspects of the immune response. In particular, 
the importance of T cells (especially CD4 T cells) in regulating the 
type of the immune response is better appreciated. 
A. EARLY MODELS 
Early studies of immune-mediated lung disease in animals were 
performed by administering different antigens via different routes and 
with different adjuvants to guinea pigs (Richerson, 1972). Immune 
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responses varied depending on the type of antigen, method of immuni- 
zation, and the presumed predominant response. Animals immunized 
with ovalbumin (OVA) in complete Freund’s adjuvant (CFA) devel- 
oped specific complement-activating antibody and hemorrhagic pneu- 
monitis with a predominant neutrophil response after aerosol antigen 
challenge. In contrast, animals immunized with ABA-N-acetyltyrosine 
in CFA exhibited DTH without demonstrable serum antibody. Later, 
OVA aerosol challenge in sensitized animals produced scattered focal 
areas of alveolitis with thickening and increased cellularity of alveolar 
septa and alveolar filling with mononuclear cells. Other work (Brent- 
jens et al., 1974) confirmed the hemorrhagic nature of immune 
complex-mediated lung disease. Hemorrhagic neutrophilic pneumoni- 
tis could be transferred with serum and suppressed by administration 
of cobra venom factor, which depletes C’ in vivo (Roska et al., 1977). 
Richerson and colleagues described the results of aerosol OVA expo- 
sure of rabbits systemically sensitized to OVA in CFA. Acute exposure 
lead to transient foci of acute pulmonary inflammation (Richerson et 
al., 1971), whereas chronic exposure caused decreasing inflammation 
(Richerson et al., 1978). T cells were prominent in both the acute and 
the chronic lesions (Upadrashta et al., 1988). Inhalation of muramyl 
dipeptide could substitute for systemic immunization with OVA in 
Freund’s adjuvant (Richerson et al., 1982). The pulmonary inflamma- 
tory response could be decreased by administration of cyclosporin A 
at the time of aerosol challenge (Kopp et al., 1985), implicating DTH 
in the etiology of pulmonary inflammation in the rabbit OVA model. 
Diminution in the pathologic response in the lungs despite continu- 
ing challenge could be produced by either repeated iv or aerosol 
exposure of rabbits to OVA and was not associated with decreased 
antigen-specific lymphocyte proliferation nor decreased blood or BAL 
antibody response (Richerson et al., 1981; Butler et al., 1982). A similar 
decrease in pulmonary inflammation has been observed in rabbits, 
guinea pigs, and mice subjected to repeated exposures to Micropo- 
lyspora faeni, the agent that causes farmer’s lung disease in humans 
(Schuyler et al., 1983,1987,1992), and Thermoactinomycetes vulgaris, 
which causes humidifier lung (Takizawa et al., 1989). 
The decrease in pulmonary inflammation during continued chal- 
lenge has been attributed to desensitization, defined as suppression of 
preexisting DTH by administration of homologous antigen. However, 
desensitization is clearly not present in the above models of lung 
disease, because lymphocyte proliferation and antibody responses 
were not depressed. Since desensitization in other systems can be 
achieved by administration of an antigen by an unusual route, such 
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as orally (Weigle, 1973), it is rather surprising that immunologic desen- 
sitization was not evident in models of repetitive pulmonary instilla- 
tion of antigen. Two other possible mechanisms, increased degradation 
of inhaled antigen or increased suppression of lymphocyte prolifera- 
tion by AM, were not present in these models (Schuyler and Schmitt, 
1985; Kopp et al., 1988). Additional possibilities, including decreased 
exposure of the lung to antigen due to changes of clearance mecha- 
nisms or change of T lymphocyte subtypes, were not investigated. 
B. IMMUNE COMPLEX-MEDIATED LUNG INJURY 
Ward and colleagues extended these studies on immune complex- 
mediated lung injury using intratracheal instillation of antibody to 
bovine serum albumin (BSA), followed by iv administration of BSA. 
Lung injury was measured using morphology, leakage of labeled intra- 
vascular protein and red blood cells into the lung, and quantitation of 
the neutrophil enzyme, myeloperoxidase, in the lung (Johnson and 
Ward, 1974). Marked differences were shown in responses to instilled 
IgG versus IgA immune complexes. 
IgG immune complex-mediated damage was characterized by neu- 
trophil infiltration into the lung and evidence of increased pulmonary 
vascular permeability. It was neutrophil dependent (Warren et al., 
1991) and required IL-lP and platelet-activating factor (Warren, 1992), 
which were likely produced by TNFa-stimulated macrophages (War- 
ren et d., 1990). Expression of VLA-4 and CD18 (Mulligan et d., 
1993b,c), functioning CR1 receptors (Mulligan et al., 1992a), and 
CDlla  (but not CDllb), and ICAM-1 expression, were also involved 
(Mulligan et al., 1993~).  There was upregulation by ELAM-1 on pulmo- 
nary venules and capillary endothelium, perhaps mediated through a 
rat analog to IL-8 (Mulligan et al., 1991,1993a), and upregulation of 
ICAM-1 expression modulated through TNFa (Mulligan et al., 1993a). 
In contrast, IgA immune complex lung injury was characterized 
by accumulation of mononuclear cells (Warren et al., 1991), perhaps 
mediated through monocyte chemoattractant protein 1 (MCP-1) ( Jones 
et al., 1992). The injury was neutrophil and TNFa independent and 
was not modulated by increases of ELAM-1 expression (Mulligan et 
al., 1992c) or TNFa secretion, despite a TNFa-induced increase of 
ELAM-1 expression. Iga-mediated injury was similar to IgG immune 
complex injury in that it was VLA-4, CD18, and ICAM-1 dependent, 
but was dissimilar in that it is more dependent on C D l l b  than CDl la  
expression (Mulligan et aZ., 1993d). IgA immune complex lung injury 
was apparently mediated through nitric oxide or its derivatives (Mulli- 
gan et al., 1992~).  IL-4 and IL-10 protected against the pulmonary 
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response to IgG immune complexes, whereas only IL-10 protected 
against IgA immune complex-mediated injury (Mulligan et al., 1993e). 
C. ASTHMA MODELS 
There are multiple animal (e.g., primate, sheep, guinea pig, dog, 
rabbit, rat) models of asthma which have been used to explore patho- 
physiologic aspects of asthma (Wegner et al., 1991; Abraham, W; Mur- 
ray et al., 1991; Lukacs et al., 1994b; Yamaya et al., 1990; Du et al., 
1992; Waserman et al., 1992; Coyle et al., 1990) and as a method to 
test the effectiveness of various therapeutic agents. Although all have 
some resemblance to human asthma, there are substantial differences, 
especially in regard to the physiologic response to airway challenge 
and in methods to induce immune hyperreactivity. Typical protocols 
use intraperitoneal administration of antigen with aluminum hydrox- 
ide and/or Bordetella adjuvants. 
Guinea pigs immunized intraperitoneally with OVA in aluminum 
hydroxide adjuvant, often with the addition of pertussis (Handley et 
al., 1992; Mauser et al., 1993), can be induced to form IgE and IgG, 
antibodies, exhibit airway and blood eosinophilia, and display early 
and late-phase bronchoconstriction (Cerasoli et al., 1991) when reex- 
posed to OVA. These animals also demonstrate increased bronchial 
reactivity to histamine or acetylcholine administered iv. Using this 
method of sensitization, guinea pigs exhibit strain differences in blood 
eosoniphilia and bronchial hyperreactivity (Winthereik et al., 1992). 
Increased responsiveness to acetylcholine after antigen challenge and 
late-phase bronchoconstriction correlates with BAL neutrophilia 
(Asano et al., 1994). This method of immunization is very different 
from that which occurs in humans, and the pulmonary physiologic 
response of guinea pigs is dissimilar to human asthma. Guinea pigs 
exposed to various parasite antigens also exhibit airway hyperreactivity 
(Yamaya et al., 1990). 
Nonhuman primates exposed to Ascaris suum antigen via the airway 
exhibit immediate skin test reactivity and either early or both early 
and late increases in airway resistance (Patterson and Harris, 1992). 
Dual responses are associated with more BAL eosinophils and a greater 
increase of BAL neutrophils (Gundel et al., 1992). 
Hirshman and colleagues found that Ascaris-sensitized basenji grey- 
hound dogs exhibited a number of changes similar to those in humans 
with asthma including increased specific and nonspecific airway reac- 
tivity and increased numbers of BAL mast cells (Hirshman et al., 1980, 
1986). Spontaneous and induced histamine release from BAL mast 
cells was increased compared to control animals (Hirshman et al., 
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1988). Tracheal muscle from these animals exhibited impairment of 
the usual increase in cyclic AMP in response to isoproterenol (Emala 
et al., 1993), and coincident with the measurement of collateral airway 
resistance, high resolution CT scanning detected airway narrowing 
(Herold et al., 1991; Corddry et al., 1991). Chronic treatment with 
methylprednisolone decreased nonspecific airway reactivity and BAL 
eosinophil number (Darowski et al., 1989). 
Others have induced an asthma-like syndrome with increased bron- 
chial reactivity and reaginic antibody in dogs immunized intraperitone- 
ally as puppies with hapten-carrier complexes in aluminum hydroxide 
adjuvant (Kepon et al., 1977). Later work extended this model by using 
ragweed antigen (Baldwin and Becker, 1993; Becker et al., 1989). 
Immunized dogs exhibited immediate- and late-phase skin test reactiv- 
ity (Becker et al., 1988), increased antigen-specific and nonspecific 
bronchial reactivity, and increased BAL mast cells, eosinophils, and 
histamine (Becker et al., 1989). 
T cells appear to be important in animal models of asthma. Frew and 
colleagues demonstrated a substantial influx of non-CD8 (presumably 
CD4+) T cells into bronchial wall mucosa and adventitia of aerosol 
antigen challenged guinea pigs undergoing late-phase bronchocon- 
striction (Frew et al., 1990). Using picryl chloride epicutaneous sensiti- 
zation, mice challenged with intranasal hapten exhibited peribronchio- 
lar cellular infiltration and increased pulmonary resistance in vivo 
(Garssen et al., 1991). Hypersensitivity to carbacol was present in 
tracheas from such animals and could be transferred with T cells from 
sensitized animals. This phenomenon could not be produced in 
athymic mice (Garssen et al., 1991). Cyclosporin A and FK506 adminis- 
tration prevented the development of both the late asthmatic response 
and bronchial hyperresponsiveness after antigen challenge (Fukuda 
et al., 1991). IL-4-deficient and class I1 MHC-deficient mice which 
lack mature CD4+ T cells could not express peribronchiolar inflamma- 
tion or BAL lymphocytosis and eosinophilia when exposed to OVA 
(Brusselle et al., 1994). Exposure of mice to certain parasites, e.g., 
Schistosomes, also caused the appearance of intrapulmonary and BAL 
eosinophilia via an IL-Cdependent mechanism (Lukacs et al., 1994b), 
perhaps by altering the balance of Th2 versus Thl  T cell numbers in 
the lungs. 
Antibody to IL-5 can ablate the eosinophilic airway response to 
OVA exposure in sensitized guinea pigs and can even block the OVA- 
induced increased sensitivity to substance P (Chand et al., 1992; Mau- 
ser et al., 1993). Eosinophil infiltration into the tracheas of sensitized 
mice after aerosol antigen challenge is dependent on CD4 cells and 
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IL-5 (Nakajima et al., 1992) and can be blocked by inoculations of 
IFNy (Iwamoto et al., 1993). 
Gelfand and colleagues (Renz et al., 1992) developed a model of 
asthma in BALB/c mice (typically high IgE responders) induced by 
repetitive inhalation of OVA. These animals exhibited increased spe- 
cific IgE production, increased sensitivity to iv methacholine, and 
evidence of sensitized cells in LALNs and spleen capable of producing 
specific IgE and IgGl. Isolated trachea from sensitized animals were 
hyperresponsive to electrical field stimulation. Specific IgE antibody 
and increased airway reactivity could be induced in naive recipients 
by transfer of sensitized cells from LALNs, but not spleen cells, fol- 
lowed by a single aerosol OVA exposure. Low-IgE responding SJL/ 
L mice failed to develop either IgE antibodies or increased bronchial 
responsiveness, although they developed specific IgG antibodies 
(Larsen and Wicht, 1962). Local airway challenge, as well as systemic 
sensitization, was required for the development of airway hyperreactiv- 
ity (Saloga et al., 1994). This suggested that local factors in addition 
to systemic sensitization were required for bronchial hyperreactivity. 
In this model, IFNy administration during OVA sensitization both 
decreased specific IgE production and ablated increased airway reac- 
tivity. The effect of IFNy was dependent on the route of administration. 
Systemic administration decreased serum-specific IgE, but not LALN- 
specific IgE production. Perhaps most importantly, the OVA-induced 
increase of airway reactivity was ablated by airway, but not systemic, 
IFNy administration (Lack et al., 1994). These results were compatible 
with an IFNy-induced shift from a predominant Th2 to a Thl  T cell 
response and also gave evidence for compartmentalization of both 
systemic and airway immune responses. Thus, airway hyperrespon- 
siveness correlated with LALN, but not systemic sensitization. 
D. T CELL-MEDIATED HYPERSENSITIVITY 
T cell-mediated inflammation in the lung can result in pulmonary 
fibrosis or hypersensitivity pneumonitis (HP). 
1 .  Hapten-lmmune Model 
Exposure of mice to a hapten instilled into the lungs caused systemic 
sensitization as measured by ear swelling after reexposure to the sensi- 
tizing hapten (Stein-Streilein, 1983). Furthermore, following epicuta- 
neous sensitization with lipophilic trinitrophenylchlorobenzene and 
an intratracheal challenge with the water-soluble hapten, trinitrophe- 
nyl, pulmonary fibrosis developed. Intratracheal rechallenge with an 
unrelated hapten (dinitrophenol) did not produce pulmonary fibrosis 
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(Stein-Streilein et al., 1987). This model was similar to previous mod- 
els of contact sensitivity using the skin for both sensitization and chal- 
lenge and was consistent with a T cell-mediated DTH process (Polack, 
1980). Different inbred mouse strains of animals exhibited coincidence 
of skin reactivity and the ability to develop pulmonary fibrosis (Kimura 
et al., 1992). Induction of tolerance by injection of hapten-coupled 
splenocytes before sensitization depressed both the skin and the pul- 
monary responses following tracheal challenge (Kimura et al., 1993). 
The inflammatory and fibrotic responses to intratracheal hapten chal- 
lenge were transferred with immune lymphocytes, but not with im- 
mune serum. In uivo administration of anti-CD4 and anti-CD8 antibod- 
ies to sensitized mice prevented or ameliorated the inflammatory and 
fibrotic responses to tracheal challenge. The development of pulmo- 
nary fibrosis is associated with BAL IL-2 activity and lymphotoxin 
mRNA in BAL nonadherent cells (Garcia et al., 1992). An increased 
ratio of procollagen type 1:III mRNA in the fibroblasts from immu- 
nized, challenged animals developed, indicating that qualitative as 
well as quantitative collagen differences occurred (Stein-Streilein et 
al., 1992). 
2.  B leom ycin-I nduced Pulmonary Fibrosis 
Bleomycin is a mixture of glycoproteins from Streptomyces uerticul- 
lus used clinically for its antineoplastic properties, but which predict- 
ably causes pulmonary fibrosis, In a hamster model, intratracheal ad- 
ministration of a single dose of bleomycin to experimental animals 
caused pulmonary fibrosis which resembled clinical pulmonary inter- 
stitial fibrosis, albeit with some differences in the pattern of fibrosis 
from usual interstitial fibrosis (Snider et al., 1978). 
Evidence has accumulated that cytokines are important media- 
tors in animal fibrosis models. Increased TGFP (Khalil et al., 1989), 
TNFa (Piguet et al., 1989a), IL-1 and IL-6 (Jordana et al., 1988), 
MCP-1 (Brieland et al., 1993), and macrophage-derived growth factor 
for fibroblasts (Denholm and Phan, 1989) have been detected in lungs 
or pulmonary cells derived from animals exposed to bleomycin. Admin- 
istration of anti-TNFa can prevent fibrosis (Piguet et al., 1989a). 
Although many of the cytokine studies concentrated on the role of 
AM, recent reports indicate that pulmonary endothelial cells constitu- 
tively produced IL-6 which is increased by exposure to bleomycin 
(Karmiol et al., 1993). MCP-1 is produced by fibroblasts (Rolfe et al., 
1992) and TGFP is produced by pulmonary artery endothelial cells 
(Phan et al., 1991,1992) or lung fibroblasts (Breen et al., 1992). There- 
fore, the source of cytokines in bleomycin-induced pulmonary fibrosis 
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could include nonmacrophage pulmonary cells as well as macro- 
phages. 
Despite the evidence of toxicity of bleomycin-induced macrophage- 
derived cytokines, several studies have suggested that T cells may 
also be important. Different strains of mice responded differently to 
intratracheal bleomycin (Schrier et al., 1983a). Pulmonary fibrosis did 
not occur in athymic nude mice (Schrier et al., 198313) and depletion 
of both CD4 and CD8 T cells prevented fibrosis (Jordana et al., 1988). 
3. E xperimen tal Hypersensitivity Pneumoni tis 
Cormier and colleagues described a model of HP associated with 
alveolitis and fibrosis, and which was caused by repeated pulmonary 
instillation of M. fueni. It was associated with increased BAL IL-la, 
IL-6, and TNFa (Denis et al., 1991). Cyclosporin A administration 
blocked pulmonary fibrosis, but not alveolitis, and BAL IL-la and 
TNFa, but not IL-6 (Denis et ul., 1992a), which suggested a role for 
T cells in producing fibrosis. Pulmonary fibrosis was also prevented 
by anti-TNFa antibody (Denis et al., 1991). Evidence was also found 
for a role for AM-secreted TGFP in promoting fibrosis (Denis and 
Ghadirian, 1992a). Secretion of TNFa, which probably originated from 
pulmonary macrophages, was fostered by CSF-1 and GM-CSF se- 
creted by lymphocytes exposed to M. faeni (Denis and Ghadirian, 
1992b). In contrast to an adoptive transfer model of HP to be described, 
in uivo depletion of T cells did not substantially affect the pulmonary 
histologic response to M. faeni (Denis et al., 1992b). This might be 
related to repetitive challenges with an agent which has adjuvant 
effects (Bice et al., 1974), so that inflammation in this model was 
macrophage, rather than lymphocyte, driven. Pulmonary fibrosis in- 
duced by repeated challenges with M. fueni, but not an increase of 
BAL inflammatory cells, was reduced by administration of anti-CD1 la, 
implicating integrins in the processes that lead to fibrosis in this model 
(Denis and Bisson, 1994). 
Lymphocytes can be implicated in other models of HP. Cyclosporin 
A administration ameliorated pulmonary lesions in animals subjected 
to airway challenges with T. uulgaris (Takizawa et al., 1988). Nude 
mice did not exhibit pulmonary lesions of HP after exposure which 
was able to produce lesions in T cell-sufficient littermates. The ability 
to express pulmonary lesions could be transferred with T cells from 
sensitized mice (Takizawa et al., 1992). 
Schuyler and colleagues have developed an adoptive transfer mu- 
rine model of experimental HP using M. faeni. Cells for adoptive 
transfer were obtained from spleen, peripheral lymph nodes, LALNs, 
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and peritoneal exudate from immunized animals. The cells were restim- 
ulated in culture with relevant antigen and could then transfer to naive 
recipients a susceptibility for increased lung inflammation following 
an intratracheal rechallenge with antigen (Schuyler et al., 1991). IFNr 
and IL-2 were present in substantial quantities in cultures (Fei et al., 
1993), and CD4 cells were required at the beginning of culture to 
generate effective cells for the adoptive transfer (Schuyler et al., 1994). 
The transferred cells were a mixture of naive and memory CD4 T cells, 
as defined by CD44, CD45RB, and L-selectin expression (Schuyler et 
al., 1994a,1992). Successful transfer was also dependent on the pres- 
ence of CD4 T cells in the recipient (Schuyler et al., 1994b), suggesting 
the necessity of an important interaction between host and recipient 
CD4 T cells. 
VI. Models for Lung Transplantation and Graft versus Host Disease 
A. LUNG ALLOGRAFT REJECTION AND GRAFT VERSUS HOST DISEASE 
Despite different methods to develop models for lung allografting or 
GVHD, the immunologic responses in the lung show similar histologic 
patterns. Several studies have documented these similarities (Atkinson 
et al., 1971; Emeson et al., 1982; Piguet et al., 1989b; Randhawa and 
Yousen, 1992; Stein-Streilein et al., 1981; Yousem et al., 1990). The 
histoincompatible allografted lung is recognized as “foreign” by the 
recipient and, therefore, is subject to rejection (Randhawa and Yousem, 
1992). In GVHD, donor immunocompetent allogenic cells recognize 
the recipient as foreign (Farrara and Deeg, 1991). 
In both of these disorders, pulmonary manifestations of lung allograft 
rejection and GVHD may be separated into acute and chronic changes. 
In acute lung allograft rejection, the initial pathologic lesions of perivas- 
cular mononuclear cell infiltrates is termed “minimal rejection” or 
grade 1 (Yousem eta,?., 1990). A more severe perivascular mononuclear 
cell infiltrate consisting of activated lymphocytes, plasma cells, and 
macrophages is called “mild acute rejection” or grade 2 (Yousem et 
al., 1990). In some instances rare eosinophils are present (Yousem et 
al., 1990). Vascular changes may include degeneration of the endothe- 
lium (endothelialitis) (Yousem et al., 1990; Randhawa and Yousem, 
1992), and lymphocytic infiltration of the bronchioles may be present 
(Yousem et al., 1990). In grade 3 acute lung cancer allograft rejection, 
also known as moderate acute rejection, infiltrates progress and be- 
come more apparent around pulmonary veins, arterioles, and peribron- 
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chiolar areas (Yousem et al., 1990). In grade 4 or “severe acute rejec- 
tion” mononuclear cell infiltrates extend into air spaces and involve 
vessels and bronchioles. Necrotizing vasculitis and parenchymal necro- 
sis may also be visible (Randhawa and Yousem, 1992). 
In contrast to acute lung allograft rejection, the pulmonary pathology 
of acute GVHD has not been assigned histologic grades. Beschorner 
et al. (1978) first described the acute changes of GVHD in the lung 
in recipients of bone marrow transplants. In these patients, the pathol- 
ogy was limited to that of lymphocytic bronchitis (Beschorner et al., 
1978). More recently, Atkinson et al. (1991) reported an acute pulmo- 
nary syndrome after bone marrow transplantation that resembled acute 
GVHD of the lung. The lesions included lymphocytic peribronchial 
infiltrates, bronchial epithelial degeneration, and lymphocytic perivas- 
cular infiltrates (Atkinson et al., 1991). Relative to the histology of 
acute lung allograft rejection, the pulmonary changes observed in 
acute GVHD of the lung are analogous to a grade 2 rejection response. 
In animal models, investigators have reported acute “GVHD-like” 
changes in the lung (Piguet et al., 1989b; Stein-Streilein et al., 1981; 
Wilkes et al., 1994a). In these studies the histologic lesions included 
alveolitis, lymphocytic bronchitis, and vasculitis. The histologic 
changes of acute GVHD were analogous to grade 4 or severe acute 
rejection in a lung allograft. In both allograft rejection and GVHD of 
the lung, the pathologic lesions of the airway began at the level of the 
bronchioles and extended into alveolar spaces. 
The chronic stage of lung allograft rejection and GVHD is associated 
with the development of bronchiolitis obliterans (BO) (Farrara and 
Deeg, 1991; Rhandhawa and Yousem, 1992; Yousem et al., 1990). 
Bronchiolitis obliterans is not a lesion specific to allograft rejection or 
GVHD and, in fact, has been associated with a variety of conditions 
(Epler, 1988) including toxic fume inhalation, rheumatoid arthritis, 
penicillamine use, postinfectious etiologies, as well as idiopathic 
causes. The histology of BO shows granulation tissue plugs within the 
lumens of the small airways, epithelial cell damage, mononuclear cell 
infiltrates, and, at times, complete obstruction of the airways (Epler, 
1988; Randhawa and Yousem, 1992). Bronchiolitis obliterans observed 
in chronic lung allograft rejection and GVHD involve the membranous 
and respiratory bronchioles, and possibly involve more proximal air- 
ways (Randhawa and Yousem, 1992). In contrast to the pathology ob- 
served in the acute disease, lymphocytic perivascular infiltrates are 
present in only 40% of BO cases associated with chronic lung allograft 
rejection (Randhawa and Yousem, 1992). The degree of vascular 
involvement in BO associated with chronic GVHD is unknown but is 
likely less than that of acute GVHD. 
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B. MODELS OF LUNG TRANSPLANTATION 
Both canine and rat models have been utilized to study lung trans- 
plantation and the immunopathogenesis of rejection (Benfield, 1976; 
Prop et al., 1985a,b). However, the availability of more immunological 
reagents has allowed the rat model developed by Marck, Prop, and 
Wildevuur to be more extensively studied (Marck et al., 1983). Or- 
thotopic transplantation of the Brown Norway rat lung allografts (RT") 
into Lewis (RT') rats resulted in histological and immunological 
changes analogous to that of human lung transplantation (Marck et al., 
1983; Prop et al., 1985a,b). The rejection process occurred in four 
phases (Prop et al., 1985a,b): (1) the latent phase which occurred 
immediately after transplantation in which no immunological activity 
was described in the graft (Day 1 after transplantation); (2) the vascular 
phase, characterized by infiltration of BALT and perivascular tissue 
by lymphocytes (Days 2 or 3 after transplantation); (3) the alveolar 
phase, with mononuclear cell infiltration of the alveolar walls (Days 
4 or 5 after transplantation); and (4) the destruction phase, character- 
ized by intraalveolar edema and destruction of airways and vessels 
by infiltrating mononuclear cells (Day 6 after post-transplantation). 
Significantly, these four phases resemble somewhat the four grades 
associated with acute rejection in humans (Yousem et al., 1990). 
While these studies described the histological changes associated 
with acute rejection, only two reports currently exist in the literature 
describing animal models of chronic rejection, known as BO (Hertz 
et al., 1993; Uyama et al., 1992). Utilizing the previously described 
rat lung allograft model, rats made tolerant to their allografts by 
cyclosporin developed the typical changes of BO around 6 months after 
transplantation. The airway lesions were associated with upregulated 
class I1 MHC expression on the epithelium in the large airways, aggre- 
gates of DCs in the submucosa, and ulcerated epithelium (Uyama et 
al., 1992). In a murine model utilizing hetertopically transplanted 
airways, the characteristic lesions of BO developed in the allograft 
after 21 days (Hertz et al., 1993). 
A significant difference between the rat models and that of clinical 
transplantation is that only one or two doses of the immunosuppressant 
drug, cyclosporin, results in indefinite acceptance of the donor rat lung 
(Uyama et al., 1992). Human lung allograft recipients usually require 
life-long therapy to prevent rejection (Trulock, 1993). However, with- 
out cyclosporin, the rat lung allograft undergoes a rapid rejection pro- 
cess which usually results in the destruction of the allograft in 7 or 8 
days posttransplantation (Prop et al., 1985a,b). 
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Although lung transplantation has become an increasingly utilized 
modality for the treatment of many endstage lung diseases (Trulock, 
1993), the lung allograft, in both animal models and humans, is more 
prone to rejection than other solid organs (Prop et al., 1985a,b; Trulock, 
1993). The presence 6f many immunocompetent cells present in the 
donor lung that can stimulate a rejection response may be the explana- 
tion (Prop et al., 1985a,b; Trulock, 1993). Notably, despite the large 
numbers of T lymphocytes present in the lung and thus carried into 
the recipient, the clinical syndrome of systemic GVHD has not been 
reported in human lung allografted individuals. However, GVHD in 
lung transplantation was reported in an animal model in which the 
recipient was rendered severely immunoincompetent by total body 
irradiation (Prop et al., 1989). 
Acute lung allograft rejection is believed to be initiated by donor 
lung APC, i.e., DCs and perhaps macrophages, interacting with recipi- 
ent lymphocytes (Winter et al., 1989). Although there is no direct 
evidence that these accessory cells mediate allograft rejection, several 
studies suggest their role in the rejection responses. Acute rejection 
episodes commonly occur at a time when there is an abundance of 
donor DCs and lung macrophages, i.e., the first 8 to 12 weeks after 
transplantation, and diminish when these cells are replaced by those 
of the recipient (Paradis et al., 1985; Uyama et al., 1993). Utilizing a 
murine model of renal transplantation in which DCs had been de- 
pleted, Lechler demonstrated that repletion of DCs resulted in the 
rejection of the allograft (Lechler and Batchelor, 1982). Similarly, 
blocking antibodies to DCs resulted in the prolongation of survival of 
murine pancreatic islet allografts (Faustman et al., 1984). As discussed 
previously, DCs exist within the epithelium and subepithelial areas 
of the bronchi/bronchioles, areas that are involved in both acute and 
chronic rejection. Additionally, IFNy, a cytokine crucial to the rejec- 
tion process (O’Connell et al., 1993), was shown to upregulate the 
number of DCs in the interstitium surrounding pulmonary capillaries, 
within the alveolar interstitium, and in the bronchial epithelium 
(Kradin et al., 1991). Finally, DCs accumulate in areas of BO during the 
course of chronic allograft rejection (Uyama et al., 1992). Collectively, 
these studies suggest a central role for DCs in the pathogenesis of 
lung allograft rejection. Lung macrophages, although suppressive of 
many immune cell functions, may also be involved in the initiation 
of the rejection response. 
Lung accessory cell-lymphocyte interactions occur through cyto- 
kines and intercellular signals and result in upregulated cellular and 
humoral immunity (Wilkes and Weissler, 1994). Cellular immunity is 
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crucial in lung allograft rejection (Prop et al., 1985a,b) and may result 
from the differential stimulation of Thl  versus Th2 cells. T h l  lympho- 
cytes play a significant role in the pathogenesis of solid organ allograft 
rejection (Jordan et al., 1991; O’Connell et al., 1983). For example, 
in a murine example of pancreatic islet rejection, allograft infiltrating 
lymphocytes preferentially expressed mRNA for IL-2 and IFNy, and 
not IL-4 (O’Connell et al., 1983). Similarly, in rat lung allografts, IFNy 
mRNA was expressed during the rejection episodes (Jordan et al., 
1991). The clinical importance of Thl  lymphocytes in allograft rejec- 
tion is exemplified by the fact that the primary immunosuppressive 
agent used in recipients of human lung allografts is cyclosporin, which 
preferentially inhibits IL-2 and IFNy production from lymphocytes 
(Cockfield et al., 1993). In contrast, Th2 lymphocyte activity, i.e., pro- 
duction of IL-4 and IL-10, which downregulates Thl  activity, has been 
strongly associated with prevention of allograft rejection (Gorczynski 
and Wojcik, 1994). Both allogeneic AM and parenchymal lung DCs 
were potent inducers of IFNy, but not IL-4, from lymphocytes (Wilkes 
and Weissler, 1994). Collectively, these data suggest that allograft 
rejection is in part mediated by lung macrophages and DCs stimulating 
Th l  lymphocytes. 
Cytokines from Th l  and Th2 lymphocytes can both result in specific 
immunoglobulin production (Kitani and Strober, 1993). Therefore, the 
upregulated Thl  lymphocyte activity observed in allograft rejection 
might be responsible for the enhanced local immunoglobulin produc- 
tion observed during the rejection process (Wilkes et al., 1994b). IFNy, 
a Th l  cytokine, can stimulate IgG2a from murine B lymphocytes 
(Kitani and Strober, 1993). Furthermore, IFNy production, induced 
by human lung macrophages, selectively stimulated IgG2 production 
from allogeneic peripheral blood mononuclear cells (Wilkes and Weis- 
sler, 1994). In recipients of lung allografts undergoing rejection, Wilkes 
(1995) demonstrated that local production of IgG2 was selectively 
upregulated and, thus, served as a marker for the rejection response 
(Wilkes et al., 1994b). Few studies have demonstrated a role for allo- 
antibodies in mediating the process of lung allograft rejection. Coro- 
nary atherosclerosis secondary to murine cardiac allograft rejection 
was in part mediated by antibodies directed against the donor coronary 
epithelium (Russell et aZ., 1994). Similarly, IgG2, but not IgGl, IgG3, 
or IgG4, produced locally during human lung allograft rejection, prefer- 
entially bound to perivascular and peribronchial extracellular connec- 
tive tissue matrices which are the anatomic locations involved in the 
rejection process (Wilkes, manuscript in preparation). Taken together, 
THE REGULATION OF PULMONARY IMMUNITY 425 
these studies suggest a role for a Thl-dependent humoral responses 
in the pathogenesis of lung allograft rejection. 
While lung accessory cell-T lymphocyte interactions initiate organ 
rejection (Winter et al., 1989), the production of proinflammatory cyto- 
kines, IL-6 and TNFa, has been identified as a mediator ofthe rejection 
process (DeMeester et al., 1993; Saito et al., 1993). Evidence that 
TNFa was involved in rejection was demonstrated by DeMeester who 
reported that TNFa mRNA and protein were upregulated in lung 
tissue during acute rejection of rat lung allografts (DeMeester et al., 
1993). Significantly, anti-TNFa antibodies reduced the vasculitis and 
hemorrhagic lesions in rejecting lung allografts (Saito et al., 1993). 
Similarly, IL-6 was upregulated in the lung during rejection and was 
postulated to be clinically important in following the activity of the 
rejection process (Rolfe et al., 1993). 
C. MODELS OF GRAFT VERSUS HOST DISEASE IN THE LUNG 
GVHD is a systemic process, and relatively few have described 
pulmonary involvement in animal models of GVHD (Piguet et al., 
198913; Stein-Streilein et al., 1981). Stein-Streilein et al. (1981), utiliz- 
ing a murine model, reported GVHD “reactions” in the lung. In these 
studies, suspensions of parental (MHA) lymph node cells were in- 
stilled into the trachea of F1 hybrid (MHA X CB) recipient hamsters. 
The histology observed in the recipient lungs showed mononuclear 
cell infiltration in the interstitium, alveolar, peribronchiolar, and peri- 
vascular areas. Some of the animals developed thymic atrophy and 
splenomegaly which suggested a systemic component to the disease 
process (Stein-Streilein et al., 1981). Interestingly, when the cells were 
given iv or intracutaneously, the animals developed systemic GVHD 
without any distinctive pulmonary pathology (Stein-Streilein et al., 
1981). 
Piguet also studied the pulmonary disease associated with GVHD. 
In these studies, irradiated F1 hybrid (CBA X B10) mice were injected 
with either parental T lymphocyte-depleted bone marrow cells or with 
parental bone marrow cells together with suspensions of lymph node 
cells as a source of T lymphocytes. In addition to the induction of 
systemic GVHD, the histology of the lung was similar to that reported 
by Stein-Streilein. Additionally, these investigators demonstrated the 
central role of T lymphocytes in the lung pathology of GVHD in that 
injection of T lymphocyte-depleted bone marrow cells did not induce 
pulmonary pathology (Piguet et al., 1989b). 
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Wilkes et al. (1994a) recently reported that allogeneic (C57BL/6) 
BAL accessory cells (>go% macrophages), when instilled intratra- 
cheally into the lungs of normal BALB/c mice weekly for 4 weeks, 
induced a lymphocytic alveolitis, bronchitis, and vasculitis analogous 
to GVHD of the lung or acute lung allograft rejection. Unlike other 
animal models of GVHD (Piguet et al., 1989b; Stein-Streilein et al., 
1981), these recipient mice had no evidence of systemic disease. Addi- 
tionally, if no further allogeneic challenges were performed, the pulmo- 
nary lesions eventually healed. 
As previously stated, the clinical manifestations of chronic GVHD 
in the lung are associated with the development of BO (Farrara and 
Deeg, 1991; Randhawa and Yousem, 1992; Yousem et al., 1990). In 
contrast, no animal models of chronic GVHD have reported an associa- 
tion with this type of pulmonary disease. 
The immunopathogenesis in animal models of GVHD has been well 
described (Antin and Farrara, 1992; Piguet et al., 198913). Similar to 
acute lung allograft rejection, acute GVHD has been associated with 
the production of several proinflammatory cytokines including TL-1, 
TNFa, and IL-6 (Antin and Farrara, 1992; Piguet et al., 1989b). In 
fact, IL-1 receptor antagonist was shown to significantly inhibit GVHD 
(McCarthy et al., 1991). Relative to the lung, anti-TNFa antibodies 
partially prevented the pulmonary pathology of GVHD (Piguet et al., 
1989b). While proinflammatory cytokines are involved in the pathogen- 
esis of GVHD, T lymphocytes initiate the process (Antin and Farrara, 
1992). Thl  lymphocytes are crucial in acute GVHD. In amurine model 
of GVHD, IFNy and IL-2 were preferentially produced in the course 
of acute GVHD (Allen et al., 1993) with similar findings to those 
reported by other investigators (Antin and Farrara, 1992). Therefore, 
the immune response to alloantigens in both lung allograft rejection 
and GVHD seems to be associated with upregulated Thl  lymphocyte 
activity. 
A role of humoral immunity in GVHD has not been well defined. 
However, Wilkes et al. reported (1994a) that allogeneic BAL cells 
instilled into murine lungs resulted in the predominant local produc- 
tion of IgG2a. Additionally, only IgG2a was shown to be deposited in 
the perivascular and peribronchiolar extracellular connective tissues, 
the same anatomic locations involved in lung allograft rejection and 
GVHD of the lung. These data suggest that locally produced immuno- 
globulins recognize component(s) of the extracellular connective tis- 
sue matrix and may be involved in the pathogenesis of GVHD of the 
lung. 
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VII. Summary 
No evidence has emerged which suggests that the principles of 
immunity derived from studies on cells from other body sites are 
contradicted in the lung and its associated lymphoid tissue. What is 
clear, however, is that the environment dictates the types of cells, 
their relationship to one another, and what perturbing events will set 
in motion either the development of an “active” immune response 
or tolerance. Investigating mechanisms for the development of lung 
immunity has increased our understanding of how human diseases 
develop and is continuing to suggest new ways to manipulate pulmo- 
nary immune responses. Demonstration that lung cells regulate both 
nonspecific inflammation and immunity through the expression of ad- 
hesion molecules and the secretion of cytokines offers hope for ways 
to design more effective vaccines, enhance microbial clearance in 
immunosuppressed hosts, and to suppress manifestations of immuno- 
logically mediated lung disease. Important lung diseases targeted for 
intensive research efforts in the immediate future are tuberculosis, 
asthma, and fibrotic lung disease. Perhaps even the common cold 
might be conquered. Considering the pace of current research on lung 
immunity, it may not be too ambitious to predict that these diseases 
may be conquered in the next decade. 
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